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Abstract

FUNCTIONAL CHARACTERIZATION OF THE STREPTOCOCCUS SANGUINIS
COM REGULON
By
Jill Elizabeth Callahan
B.A. Biology, Saint Anselm College, 1998
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2011
Major Director: Todd Kitten, Ph.D.
Associate Professor, Philips Institute, School of Dentistry

Streptococcus sanguinis is an important component of the dental plaque biofilm
and is believed to play a beneficial role in the oral cavity. S. sanguinis is also a leading
cause of infective endocarditis (IE), a potentially lethal infection of the cardiac valves. S.
sanguinis possesses genetic competence, the ability to acquire exogenous DNA into its
genome. In the well characterized system of S. pneumoniae, genetic competence requires a
quorum sensing system encoded by the early comCDE genes, as well as late genes
xvi

controlled by the alternate sigma factor, ComX. Previous studies in other streptococcal
species have suggested functions for the com regulon apart from DNA uptake. Here we
characterized functions of the S. sanguinis com regulon genes in genetic competence, IE
virulence, and biofilm formation. Our findings indicated that the early regulatory genes and
those under the control of ComX in S. sanguinis play similar roles in genetic competence
as their orthologs in other competent streptococci; however the sequence and mechanism
of processing of the quorum sensing signal, competence-stimulating peptide, CSP, were
determined to be unique. Using a rabbit endocarditis model, we determined that the
comCDE and comX genes were not required for virulence, bacteremia, or pathology under
a variety of infection conditions. In contrast, examination of biofilms by microscopy and
crystal violet staining indicated that S. sanguinis CSP enhanced biofilm formation in a
comDE-dependent manner. Deletion of the early com gene SSA_0195 eliminated this
effect, while expression of the gene from an inducible promoter increased biofilm
formation in the absence of CSP. Deletion of the comX gene resulted in biofilms with
increased staining, cell death, and profoundly altered structure. Treatment with DNase I
reduced biofilm formation in a com-independent manner. Taken together, these results
suggest that expression of SSA_0195 is both necessary and sufficient for CSP-dependent
biofilm enhancement, and that the late gene activator, ComX, is required to maintain
normal biofilm architecture. Our findings suggest the com regulon of S. sanguinis may be
an important determinant of competitiveness in the mouth, where native CSP production
may occur at levels sufficient to influence biofilm formation.

xvii

CHAPTER 1: INTRODUCTION

Streptococci
The streptococci consist of Gram positive, catalase-negative, non-motile,
microaerobic and non-spore forming bacteria. They divide in a single plane resulting in
characteristic chains or diplococci. The earliest known attempts for classification of the
streptococci were performed in 1903 by Shotmuller et al, and were based upon hemolysis
patterns on blood agar plates (41). The three main types of hemolysis patterns observed
within Streptococcus are alpha-hemolysis in which strains partially lyse red blood cells
(RBC) and colonies have a green halo on the plate, beta-hemolysis where strains
completely lyse RBC, resulting in a clearing around colonies, and gamma-hemolysis,
which is the name given to an absence of hemolysis. Later classifications described by
Lancefield (85) involved classification of the beta-hemolytic species into immunological
groups based on the presence of specific cell wall antigens.
The classification of the streptococci has long remained a problematic area of
taxonomy (14). Within the past 30 years, the classification of the streptococci has
undergone many changes due to the recent increase in 16S rRNA sequencing, 16S – 23S
intergenic spacer sequencing, cluster analysis, multilocus sequence analysis (MLSA) and
DNA-DNA hybridization (3, 14, 41, 155). The genus Streptococcus now includes over
1

fifty species, most of which have been placed into six major phylogenetic groups based
upon 16S rRNA sequencing– the Pyogenic streptococci, Mitis, Anginosus, Salivarius,
Mutans, and Bovis groups (14). The viridans streptococci include Mitis, Anginosus, and
Salivarius groups.

Viridans Streptococci
The term “viridans streptococci” refers to the alpha hemolysis pattern observed on
blood plates which is characterized by a green pigmentation, due to oxidation of
hemoglobin in RBC (7). In the past, the terms “oral streptococci” and “viridans
streptococci” have been used interchangeably. However care should be used when
employing these terms. Several of the recognized viridans species include beta- and
gamma- hemolytic species, or may occupy niches outside the mouth (164). These may
include the genital tract (134) or intestines (160). The majority of oral and viridans
streptococci, however, can be located in the hard and soft tissue of the oral cavity and
within the nasopharynx, and most studies have focused on their role within this niche.

Biofilms and oral streptococci
Biofilms are organized communities of surface adherent microorganisms embedded
in an exopolysaccharide matrix (EPS). The components of the EPS can contain a wide
variety of polysaccharides, proteins, glycoproteins, and extracellular DNA (eDNA). DNA
was first identified as a component of the extracellular matrix in Pseudomonas aeruginosa
biofilms(165). Biofilms may consist of dense clusters of bacterial cells which aggregate
2

together. Biofilm formation occurs in a series of distinct steps including initial adherence,
irreversible attachment, maturation, and dispersion(117). Unlike planktonic cells, bacterial
cells living within a biofilm may exhibit increased resistance to antimicrobial agents and
the immune response of the host (15).
Biofilms may consist of one species of bacteria or several species, as in the case of
dental plaque (146). The oral plaque biofilm comprises more than 700 species, of which
approximately 20% are streptococci (1). Predominant species occurring in dental plaque
can be divided into early colonizers, bridge species, and late colonizers. Streptococci are
among the earliest colonizers on a freshly cleaned tooth surface (79, 91, 149). Adherence
occurs through specific receptor-ligand interactions on the bacterial cell surface and the
acquired pellicle consisting of salivary glycoproteins (113) including salivary agglutinin
and sialylated mucins (79). Important streptococcal early colonizers are members of the
mitis group and include the species S. oralis, S. sanguinis, S. gordonii and S. mitis.
However cariogenic species from the Mutans group (43) are also found on the tooth
surface. Other early colonizers that bind to the streptococcal species include Haemophilus
parainfluenzae, Capnocytophaga ochracea and Prevotella denticola. Fusobacterium
nucleatum is considered the bridge species between the early colonizers and the late
colonizers, which can include species implicated in periodontitis, including
Porphyromonas gingivalis, Prevotella intermedia, and Treponema denticola (79).
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Streptococcus sanguinis
Streptococcus sanguinis (formerly known as S. sanguis (154)) can be classified
among the mitis group of viridans streptococci (72, 164). S. sanguinis exists among
normal oral flora as a pioneer colonizer of the tooth surface, serving as a tether for
numerous bacteria within dental plaque (1, 78). There is evidence that S. sanguinis is
correlated with a “healthy plaque” as S. sanguinis is often associated with tooth surfaces
free of caries (10). S. sanguinis may interfere with colonization of the tooth by S. mutans
(19) and other oral pathogens (142). However, because of its presence on the teeth, S.
sanguinis may easily be seeded into the bloodstream through oral surgery or everyday
activities including chewing or brushing (138, 166). In persons with certain preexisting
conditions that cause cardiac damage, blood-borne oral streptococci, including S. sanguinis
(27, 37, 83), may adhere to the damaged tissue, resulting in infective endocarditis (166).

Infective Endocarditis
Infective endocarditis (IE) is a rare, yet highly lethal condition if left untreated. IE
is an infection of the cardiac valves or endocardium most often caused by bacteria;
however cases caused by fungi have been reported (13). Each year in the U.S. there are
approximately 15,000 new cases (123) with incidence higher in males than females by
approximately two to three-fold (140). Susceptibility to IE infection appears to increase
with age as greater than half of all cases of IE are in those older than 60 years (123);
however, incidence is increasing among younger individuals with a history of intravenous
(IV) drug use (104). Depending on the severity of clinical presentation, classification, and
4

level of progression, IE can be characterized as “acute” or “subacute- chronic” (114). IE
can be classified into four main categories including native valve endocarditis (NVE),
prosthetic-valve endocarditis (PVE), infective endocarditis in IV drug users, and
nosocomial IE (108).
Risk factors for NVE include rheumatic heart disease, congenital heart disease
(108), and mitral valve prolapses (MVP) (114). Most cases of NVE manifest as “left
sided,” that is most commonly occurring in the mitral or aortic valves. Among cases of
NVE, approximately 44% are caused by the staphylococci and 31% by streptococci (108).
Among the streptococci, oral streptococci are the most common cause of IE, with
Streptococcus sanguinis frequently reported as the most commonly isolated oral species
(27).
Approximately 1-5% of IE cases result from the introduction of a prosthetic valve.
PVE can be classified as early or late, depending on whether infection occurred within the
first 2 months of surgery or later. Early cases of PVE are most often due to S. epidermidus
or S. aureus, while later cases involved streptococci and the Gram negative HACEK group
(Haemophilus spp., Actinobacillus actinomycetemcomitans, Cardiobacterium hominus,
Eikenella corrodens, and Kingella kingae) (108, 114). With regard to nosocomial IE, most
cases are caused by the enterococci and staphylococci with many patients lacking cardiac
predisposing factors and introduction of bacteria occurring through catheters (108). IV
drug users more often present with the right side (tricuspid valve) IE, with organisms often
entering from the skin, with S. aureus as the most common and Pseudomonas also
prevalent (108).
5

IE Clinical Manifestations, Diagnosis, Treatment
Many cases of IE are left undiagnosed due to nonspecific symptoms, mimicking the
flu. These include fever, weight loss, general malaise, loss of appetite and night sweats.
The presence of a heart murmur can also be indicative of IE, although in many patients this
is a preexisting condition due to valve dysfunction. Peripheral manifestations include
petechiae on the skin, conjunctiva and oral mucosa, splinter hemorrhages under the nails,
Osler’s nodes (tender, subcutaneous nodules on the digits), and Janeway’s lesions
(hemorrhagic lesions on the soles of the feet) (114, 115).
Definitive diagnosis of IE requires incorporating clinical symptoms,
microbiological isolation and identification, and transesophageal echocardiogram (TEE)
examination. These parameters collectively known as the “Duke’s criteria” were
established in 1994, by David Durack at Duke University (35) and modified in 2000 to
incorporate S. aureus, Coxiella burnetti, and negative blood cultures (92). Duke’s criteria
can be divided into major criteria and minor criteria. Major criteria involve a positive
blood culture of typical IE organisms (including viridans streptococci, S. aureus,
enterococci, and the HACEK group.) These blood identifications must involve either two
positive draws twelve hours apart, or three to four positive draws spread out over an hour.
Another major criterion for IE is a positive echocardiogram, which may allow visualization
of an oscillating mass on a valve, abscess, or partial dehiscence of a prosthetic valve.
Minor criteria involve history of IV drug use, and presence of symptoms described above.
Diagnosis may be definite, possible or rejected depending on the number and combination
of both major and minor criteria seen (108).
6

Currently there is no vaccine for IE. Prevention of IE has traditionally relied on
prophylactic treatment with antibiotics before dental or other surgeries that induce
bacteremia. However the efficacy of this prophylaxis has been called into question, as the
number or cases of IE has remained steady throughout the years and there is little evidence
of protection from such measures. Further, increasing evidence exists that oral bacteria
may enter the blood through everyday activities including tooth brushing or chewing (45,
51, 135). Also due to the steady increase in antibiotic resistance, risk of anaphylaxis, and
seemingly rare incidence in IE within the population, recent revisions in prevention
strategies have focused on maintenance of good oral hygiene, rather than administering
antibiotics. In 2007, the American Heart Association made modifications to its guidelines
in the prevention of IE, greatly limiting those who are recommended to receive such
prophylaxis. However for at-risk individuals undergoing procedures in which significant
bleeding of the gingival tissue or periapical region is expected, a single oral dose of 2g
amoxillicin may be administered thirty to sixty minutes prior to procedure (166).

IE Pathogenesis of Oral Streptococci
NVE pathogenesis is thought to occur in a series of distinct steps. Most cases of
NVE occur in patients with pre-existing damage to the cardiac valve endothelium, in which
the deposition of extracellular matrix proteins, fibrin, and platelets form a “vegetation”.
Oral streptococci may be introduced into the bloodstream through a bacteremic event such
as brushing, chewing and/ or oral dental procedures. In the first step, which occurs within
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minutes of a bacteremic event, bacteria adhere to the vegetation tissue. This adherence may
involve a family of sialic acid-binding adhesins (73, 147).
The second step involves establishment and persistence of the bacteria within the
site of attachment. In the third step, microbial growth continues and may be coupled with
tissue damage resulting from the persistence of monocytes producing tissue factor activity
(TFA) and cytokines. In the last step, dissemination to distant tissue including the kidneys
and brain may occur (108, 109) resulting in such conditions as stroke, brain abscesses,
glomerulonephritis, and ultimately death if left untreated (123).

Genetic competence
Genetic competence refers to the ability of certain bacteria to take up and
incorporate free exogenous DNA (146). Genetic competence is believed to be
instrumental for bacteria to adapt to their environment and often contributes to an increase
in clinical severity, as in the case of uptake of antibiotic resistance genes. In bacteria, the
incorporation of naked DNA into the genome is known as transformation. Transformation
was first observed in S. pneumoniae by Griffith in 1928 (48) when he noted a heat killed
virulent strain mixed with a live avirulent strain could be lethal. It was later determined
that DNA was the transforming factor (6). DNA uptake has been well studied in both the
gram positive and gram negative bacteria. Within the gram positive bacteria, studies in
Bacillus subtilis and S. pneumoniae have demonstrated three main steps are involved. In
the first of these steps, dsDNA binds to the cell surface, next the bound DNA undergoes
fragmentation, and lastly ssDNA is transported into the cell while the untransported strand
8

is degraded (32). Further, it has been observed that binding of dsDNA does not require
sequence specificity in either S. pneumoniae or B. subtilis (46).

Genetic competence in the streptococci
The process of transformation is best understood in the mitis group species, S.
pneumoniae, where it was initially discovered. Within this species, it was first observed
that a culture’s ability to be transformed is dependant upon cell density and would
diminish rapidly over time (152). Such observations suggested a model of quorum sensing
(QS), in which bacteria can communicate with each other in response to environmental
conditions (106). Additional studies by Tomasz et al indicated the presence of a secreted
competence factor (151) which could be isolated from supernatant of competent strains
(150). Later studies by Havarstein et al identified this secreted factor, competencestimulating peptide (CSP) encoded by comC (56). S. pneumoniae ComC is produced as a
41 amino acid precursor peptide which is then processed and secreted to its active form,
CSP, a 17 amino acid peptide.
Studies were performed to identify and map additional com genes using insertionduplication mutagenesis (20) and revealed the presence of two neighboring genes, comA
and comB encoding proteins of 77kDa and 49 kDa respectively (21). When either of these
genes was deleted, competence was lost but restored in the presence of added secreted
competence factor (20). Sequence analysis of ComA indicated it was a member of the
ATP-binding cassette transporter family, suggesting it was responsible for secretion of
CSP (66). ComA and ComB demonstrated strong sequence similarities to proteins
9

involved in the transport of Gly-Gly bacteriocins (67). Proteins of this family are known
to recognize this double glycine motif and cleave the prepeptide to its active form
concomitant with export (21, 30, 69).The sequence of ComC within S. pneumoniae and
most other competent streptococci possess this GG motif . Later studies in S. pneumoniae
ATCC 49619 revealed residues Cys17 and His96 of ComA are essential for proteolytic
activity (69).
Additional sequencing downstream of comC revealed the presence of comD and
comE (128), which demonstrated homology to two component regulatory systems (143).
ComD and ComE exhibit a high level of homology to the transmembrane histidine kinase
proteins (HK) and response regulator (RR) families, respectively (128). In a typical
cascade, a stimulus activates the HK and adenosine triphosphate (ATP) phosphorylates
histidine residues, which next transfers a phosphoryl group to their cognate RR on a
conserved aspartic acid residue (143). It was therefore proposed that CSP was the stimulus
activating this TCS, with RR ComE upregulating comAB and comCDE (128). It was
demonstrated by Havarstein et al that ComD served as the receptor of CSP (58), and Ween
et al elucidated the DNA binding activity of ComE (162). Ween’s study demonstrated that
ComE functions autocatalytically by binding to its own promoter and upstream of comAB.
The binding site of ComE was shown to be a ≈ 9- bp direct repeat of aCAtTTcaG (162)
separated by 12 or 13 nucleotides (28).
Using a variety approaches including genome sequencing, bioinformatics and
genomic libraries, additional competence genes involved in DNA uptake were identified.
These included competence induced loci (cil) genes (18) which exhibited high levels of
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homology to competence genes previously seen in B. subtilis, Haemophilus influenzae, and
Neisseria gonorrhoeae. Among these genes, which were required for competence, were
homologues to cilA, a ssDNA binding protein, cilB, involved in DNA processing, cilC, a
prepilin peptidase, cilD involved in DNA binding and pilin production and cilE (comEA),
involved in DNA binding and uptake (18). Genes within this locus all possessed a
conserved upstream (-10) region of 8 nucleotides, TACGAATA, known as the com-box
which was required for induction of these genes (18). This com-box was not observed
upstream of comAB or comCDE, therefore suggesting induction of the cil locus by other
means (88). A search for this regulator used purified S. pneumoniae RNA polymerase
holoenzyme, and revealed an interaction of a protein associated with cilA transcription,
sigma factor ComX. comX was present in two identical copies with the presence of either
sufficient for competence. Activity of ComX was observed to be dependent upon ComE
(88). A later study on ComX revealed another protein, ComW, serves to stabilize and
activate ComX by an unknown mechanism (145).
Competence (com) genes have been separated into two groups based on temporal
expression and whether there are controlled by ComE or ComX. Collectively, the ComEdependent genes, are referred to as “early” because their expression is upregulated
immediately following CSP addition, and reaches maximum levels between 7.5 and 10
minutes post-induction (130). The ComX-dependent genes are referred to as “late”
because they experience a lag in induction after CSP addition and reach maximum levels at
approximately 12.5 minutes post-induction (130). Microarray analysis indicates that CSP
upregulates approximately 124 genes in S. pneumoniae; however, only 23 of these have
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been shown to be required for DNA uptake (131). Based on the identification of the
aforementioned genes, a summary model of the S. pneumoniae com regulatory genes has
been put forth and is illustrated in Fig.1.
It has been observed that loss of ComA, ComB, or ComC results in diminishment
of competence. Since these three proteins function to produce and export mature CSP, their
loss can be overcome by the addition of synthetic CSP to the culture medium. Mutation of
the genes encoding ComD, ComE, or ComX results in loss of competence, even in the
presence of added CSP (131).
Much of our understanding of S. pneumoniae com genes is based on the study of
another competent Gram positive species, B. subtilis, as many genes were identified
through homology searches (18, 87). Further, the mechanisms regulating genetic
competence within B. subtilis are very similar to that of S. pneumoniae. In B. subtilis
genetic competence occurs approximately two hours following the onset of stationary
phase. In B. subtilis competence is similarly regulated via a two component system (TCS)
as follows. First, extracellular, post- translationally modified, competence pheromone,
ComX is sensed by HK, ComP which becomes phosphorylated. ComP then transfers its
phosphoryl group to response regulator ComA. This interaction of ComA and ComP
activates the transcription of comS. ComS in turn allows for accumulation of ComK
through preventing its proteolysis. ComK is a transcriptional activator which drives
expression of the com genes and serves in a positive feedback loop, further driving its own
expression (153).
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Figure 1. S. pneumoniae com regulon model
1. comC gene encodes precursor peptide, ComC
2. Com C is cleaved and exported by the products of the comAB operon, ABC
transporter with peptidase activity, ComA, and integral membrane protein
ComB.
3. The mature ComC peptide, termed “competence stimulating peptide” (CSP)
accumulates in the extracellular matrix and is sensed by the transmembrane
(HK), ComD. ComD responds by activation through autophosphorylation of
histidine residues.
4. ComD then transfers phosphoryl groups to conserved aspartic acid residue on
the ComE (RR). Phosphorylated ComE activates expression of the comAB and
comCDE operons through binding the comE box. ComE also activates comX
which is present in two identical copies.
5. ComX serves as an alternative sigma factor, directing the expression of “late”
genes required for uptake and incorporation of DNA.
6. Among the late genes are the comY operon, which encodes a pseudopilus,
involved in the binding of DNA with DNA receptors on the cell surface.
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Figure 1.

σ
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The DNA uptake machinery is also similar within the two species. B. subtilis
possesses a competence pseudopilus encoded by the seven gene operon, comG (16, 24)
that allows exogenous DNA access to ComEA. ComEA is an integral membrane protein
that binds DNA at the C-terminal domain, external to the cell (33). ComEA orthologs
have been shown to be essential for DNA transport in S. pneumoniae (32). Homologues to
the comG operon within the streptococci occur in a four gene operon, known as cglA-D in
S. pneumoniae (131) or comY-D in S. gordonii (99).
In B. subtilis, cleavage of bound dsDNA occurs immediately through activity of
endonuclease NucA (133). Although mechanisms for the cleavage of dsDNA prior to cell
entry in the streptococci are not fully understood, it has been demonstrated that single
stranded nicks (84) in DNA occur followed by double stranded breaks (110). One strand is
degraded by nuclease EndA (32). Once DNA is has been linearized, it is transported into
the cell by ComEC. ComEC is a polytopic membrane protein with at least six membranespanning segments. ComEC is believed to form an aqueous channel for DNA (32). Once
DNA enters the cell it is believed to recombine with the chromosome in a RecAdependent process depending on a high level of homology between foreign and host DNA
(11).
Streptococcal species known to be naturally competent include S. pneumoniae, S.
gordonii, S. sanguinis and S. mutans. The increase in whole genome sequencing and
transcriptome analysis within the streptococci has increased our understanding of
similarities and differences in mechanisms of competence existing within the genus. We
now know that in S. gordonii (98), S. sanguinis (136) and S. pneumoniae (59), the onset of
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competence occurs at early exponential phase. Within S. pneumoniae many pherotypes of
CSP exist, with two predominating (132, 163). Additionally the comCDE operon is
present within the anginosus groups (59), suggesting the regulatory mechanisms of
competence may be similar within these groups.
Within S. mutans several key differences from S. pneumoniae in the competence
system have been identified. In S. pneumoniae, competence induction occurs within five
minutes of CSP exposure (131), while there is an approximate delay of two hours (2) in S.
mutans. There has only been one pherotype of S. mutans identified, although minor
variations may exist among strains (4). Additionally, no binding motif for ComE is
present in the promoter region of ComX in S. mutans, (90)and transformation frequency is
much lower (112) than observed S. pneumoniae, being only ≈ 1% of the population.
Further, microarray studies revealed a high proportion of CSP-upregulated genes related to
bacteriocin production (127), suggesting the main function of this system is for production
of bacteriocins rather than DNA uptake (159).

com genes in S. sanguinis
The genome of S. sanguinis SK36 has recently been sequenced and was shown to
contain a single circular DNA molecule containing approximately 2.4 Mb. S. sanguinis is
naturally competent, and it is estimated that at least 270 of its 2274 genes were acquired
through horizontal gene transfer. No evidence of conjugative plasmids or phage genes
exists, suggesting natural transformation as the most frequent method of gene acquisition
(168). We have recently noted several key similarities and differences in genetic
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competence in S. sanguinis compared to S. pneumoniae. Competence was found to
develop in S. sanguinis during the early exponential growth phase (OD660 ≈ 0.070) (136),
as in S. pneumoniae (56, 152). Microarray and RT-PCR studies performed with a comC
mutant suggested upregulation of 124 genes in S. sanguinis in response to CSP (136).
Further, the sequencing of S. sanguinis revealed four putative orthologs of the early
regulatory genes of genetic competence, the comCDE operon and comX. However the
sequencing of S. sanguinis failed to identify comAB or comW orthologs (168).
ComC maturation and secretion in the streptococci
From what is known of competence induction in S. pneumoniae, it is clear that a
key step in the initiation of competence is the cleavage and export of ComC to produce
extracellular CSP. The S. pneumoniae ComC cleavage site was identified by isolation and
sequencing of the mature CSP molecule (56). Alignment of the ComC sequence of S.
pneumoniae with that of several other streptococci demonstrates a conserved glycineglycine (GG) motif just upstream from the cleavage site (Fig. 2). This places S.
pneumoniae ComC within a large family of peptides that undergo cleavage at a GG motif
concomitant with export t(30). Likewise, the ComA ABC transporter that was shown to be
responsible for cleavage of ComC in S. pneumoniae (66) contains a motif that exhibits
strong homology to the Peptidase C39 family (67). Proteins in this family are known to
recognize the GG motif and cleave the prepeptide to its active form concomitant with
export (21, 30, 69). Other peptides that contain the GG motif, including bacteriocins, have
also been shown to be processed by peptidases belonging to this family (29, 30, 70). In
gram positive bacteria, bacteriocins are small heat stable peptides that are used to enhance
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colonization by eliminating competing strains or species. ComB is required for CSP
transport in S. pneumoniae and has homology to bacteriocin transport proteins, but its
exact function is not known (67). Figure 2 indicates that S. sanguinis ComC lacks a
characteristic GG cleavage signal; however, Havarstein et al reasoned that cleavage likely
occurred after the FW due to the conserved Arg residue in the +3 position. Further, this
group demonstrated that a synthetic peptide with sequence DLRGVPNPWGWIFGR
stimulated competence in S. sanguinis (59).
This suggests that S. sanguinis ComC is also cleaved, although probably not by a
Peptidase C39 family member. This likely explains why ComA orthologs have been
readily identified in every species listed in Fig. 2 except S. sanguinis, despite the
availability of the S. sanguinis genome sequence (168). As seen in Fig. 2, the sequence of
ComC in S. sanguinis appears to be unique, and a BlastP (5) search for S. sanguinis ComC
homologs does not produce any significant matches. Further, a Blocks database analysis
(62) showed that S. sanguinis ComC did not appear to have homology to motifs in any
known family of peptides, and the exact sequence of secreted CSP remains unknown.
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Figure 2. ComC sequences of S. sanguinis and other naturally competent
streptococci.
Underlined sequences indicate demonstrated or proposed cleavage recognition sequences.
Sequences occurring after the dash indicate demonstrated or proposed sequences of the
mature, cleaved CSP from each species.
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Figure 2.
S.
S.
S.
S.
S.
S.
S.
S.
S.
S.
S.
S.
S.

pneumoniae
MKNTVKLEQFVALKEKDLQKIKGG-EMRLSKFFRDFILQRKK
oralis
MKNTVKLEQFVALKEKDLQEIKGG-EMRLPKILRDFIFPRKK
mitis
MKNTVKLEQFKEVTEAELQEIRGG-DWRISETIRNLIFPRRK
infantis
MEKTVKLEQFKKLTEKELQEIQGG-DWRFLNSIRDLIFPKRK
cristatus
MKNTQKNFKTIAQFPVLNEKELKEVLGG-DLRNIFLKIKFKKK
oligofermentans
MKNTQKNFKTIAYFPVLNEKELKEVFGG-DSRNILKIKFKKK
constellatus
MKKIFSKKEITKVEVESFKELTDEQLNKIVGG-DSRIRMGFDFSKLFGK
anginosus
MKKLFAKKEVVKKEVVEFKELNDEQLDKIIGG-DSRIRMGFDFSKLFGK
milleri
MKKIFSKKEITKVEVESFKELTDEQLNKIVGG-DRRDPRGIIGIGKKLFG
gordonii
MKKKNKQNLLPKELQQFEILTERKLEQVTGG-DVRSNKIRLWWENIFFNKK
mutans
MKKTLSLKNDFKEIKTDELEIIIGG-SGSLSTFFRLFNRSFTQALGK
sanguinis SK36
MKIYSFQIALNSNSLVQTFW-DLRGVPNPWGWIFGR
sanguinis NCTC 7863
MKIYSFQIAANSNSLVQTFW-DLRGVPNPWGWIFGR
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Research Objectives
S. sanguinis plays a benign or beneficial role within the mouth; however, it is a
leading cause of infective endocarditis, a potentially fatal infection of the cardiac valves.
Within other streptococcal species, genetic competence genes have been seen to contribute
to both virulence and persistence in the oral biofilm, dental plaque. Recent sequencing of
S. sanguinis has revealed this regulon has helped to shape its genome; however orthologs
of important streptococcal regulatory competence (com) genes were not identified. This
includes the gene(s) necessary for processing and secretion of the competence quorum
sensing signal, CSP, or competence stimulating peptide. The goal of the project described
here is to further characterize the mechanism of genetic competence within Streptococcus
sanguinis, and in doing this, determine the role of this system in endocarditis virulence and
biofilm formation. This was addressed through three key aims. In the first aim, mutants of
com ortholog genes were constructed and analyzed for competence, the mature CSP was
isolated and identified, and candidates for its processing and transport were tested. In the
second aim, endocarditis virulence was assessed in mutants of the com regulatory genes
relative to a virulent wild type strain using a well characterized rabbit model. In the third
aim, roles of the com regulon in biofilm formation were evaluated using staining and
microscopy. We uncovered novel regulatory mechanisms existing with the com regulon of
S. sanguinis. Additionally, we sought to determine mechanisms to inhibit endocarditis
virulence without eliminating the benefits of S. sanguinis persistence within the mouth.
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CHAPTER 2: MATERIALS AND METHODS
Bacterial strains and growth conditions
S. sanguinis SK36, isolated from human dental plaque (74, 168), was used in these
studies. Strains derived from SK36 and plasmids used in this study are listed in Table 1.
SK36 and derivates were grown at 37° C in Anoxomat jars (Spiral Biotech) under
microaerobic conditions (7.2% H2, 7.2 % CO2, 79.6% N2, and 6% O2) or anaerobic
conditions on Brain Heart Infusion (BHI; Bacto, Sparks, MD) plates with 1.5% agar or in
BHI broth, except as noted below. For transformations, S. sanguinis strains were grown in
Todd Hewitt broth (Bacto, Sparks, MD) adjusted to pH 7.6 containing 2.5% horse serum
(Invitrogen) (THHS) (122, 156)and incubated with transforming DNA. For streptococcal
selection, chloramphenicol (Cm), erythromycin (Em), spectinomycin (Sc) and kanamycin
(Kn) were employed at 5 μg/ml, 10 μg/ml, 200 μg/ml, and 500 μg/ml, respectively. Strains
were cryopreserved in media with respective antibiotic plus 30% glycerol at -80 °C.
Electromax DH10B (Invitrogen) was used as the host strain for plasmid construction in
Escherichia coli. Em and Sc were added to Luria-Bertani medium or terrific broth (TB)
(148)at concentrations of 300 μg/ml and 50 μg/ml, respectively for selection.
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Table 1. Strains and plasmids used in this study
Strain or plasmid

Description

Reference

S. sanguinis
Strains
SK36

Human plaque isolate

JFP41
JFP36
JFP45
JFP49
JFP60
JFP61

ΔcomC; derived from SK36
Emr; SSA_0169::pSerm; derived from SK36
Knr; ΔcomX::aphA-3; derived from SK36
Scr; ΔcomCDE::aad9; derived from SK36
ΔcomC, ΔcomX::aphA-3; derived from JFP41
Scr; ΔSSA_1889::aad9; Knr ΔSSA_0195::aphA-3,
derived from SK36
Scr; ΔSSA_1889::aad9; derived from SK36
Knr; ΔSSA_0195::aphA-3, derived from SK36
Knr; ΔSSA_0195::aphA-3(pJFP94)
ΔcomC (pJFP94)
ΔcomC (pVA838)
Knr; ΔSSA_0195::aphA-3(pVA838)
ΔcomC, ΔcomX::aphA-3 (pJFP94)
ΔcomC, ΔcomX::aphA-3 (pVA838)

JFP65
Ssx_0195
JFP95
JFP96
JFP97
JFP98
JFP113
JFP114
Plasmids
pJFP16
pVA838
pDR110
pJFP93
pJFP94

Knr Cmr; pVA2606 containing 3.3 kb
nrdD1::magellan2
Emr; E. coli-Streptococcus shuttle vector
Scr; bla amyE::Pspank
Scr; pDR110 containing SSA_0195 fused to Pspank
Emr; pVA838 containing 2.5-kb EcoRI/BamHI
fragment from pJFP93 comprised of SSA_0195 fused
to Pspank
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(74, 168)
(136)
(156)
This study
This study
This study
This study
This study
(23)
This study
This study
This study
This study
This study
This study
(156)
(100)
D. Rudner
This study
This study

DNA Manipulations
Chromosomal S. sanguinis, SK36 DNA was isolated as described previously (75).
DNA amplification by PCR was routinely performed in an MJ Research PCT-200 thermal
cycler (Bio-Rad). PCR amplification was performed using Platinum ® PCR Supermix
(Supermix) or High Fidelity Platinum ® PCR Supermix (HIFI Supermix) (Invitrogen).
Oligonucleotide primers were synthesized by Integrated DNA Technologies (IDT).
Restriction enzymes used were acquired from New England Biolabs Inc., and used as
indicated by the manufacturer. DNA purification from agarose was routinely performed
using a QIAquick Gel Extraction Kit (Qiagen) The QiaPrep Spin Miniprep Kit (Qiagen)
was used for plasmid DNA extraction from E. coli. Purification of PCR products was
performed using the MinElute PCR Purification kit (Qiagen) using a centrifuge. Real-time
quantitative PCR was preformed with a 7500 Fast Real Time PCR System (Applied
Biosystems). For E. coli cloning, T4 DNA ligase (Invitrogen) and corresponding buffer
was normally used, as directed by the manufacturer.

Transformation
Transformation was used in mutant generation and as a measure of competence
using a modification of a previously described transformation assay (136). In this, 50 μl of
overnight cultures of each strain were diluted in 10 ml of prewarmed THHS and incubated
at 37°C until reaching an OD660 of approximately 0.07. For assessment competence
aliquots of 330μl were added to prewarmed 0.7-ml microcentrifuge tubes containing ± 70
ng synthetic S. sanguinis CSP (59) and 10 ng pJFP16 (156), a suicide plasmid encoding
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chloramphenicol (Cm) resistance, and incubated at 37°C for 60 to 90 min. When multiple
strains were assessed simultaneously, as in late com strains, DNA ± 70 ng was added to
strains at 2 h, OD was noted and incubation was increased to 3 h for greater sensitivity.
Dilutions were then drop-plated (105) on BHI agar plates and enumerated. During
competence assessment, transformation frequency was measured following 48 h
incubation as total CFU/ ml on BHI plates containing Cm divided by total CFU/ml from
plates with no antibiotic. The effect of CSP on viability was measured as CFU/ml of cells
incubated with CSP divided by CFU/ml of cells incubated without CSP.

Creation of S. sanguinis mutant strains
comCDE
Deletion of the comCDE operon was performed using an overlap extension PCR
technique (65), in which the comCDE operon was replaced with the aad9 Scr cassette of
pR412 (101). Three separate PCR reactions were performed. The comCDEup1 and
comCDEdn2 primers were used for amplification of the 1-kb region upstream of comCDE,
the comCDEup3 and comCDEdn4 primers for the aad9 cassette, and the comCDEup5 and
comCDEdn6 primers for the 0.8-kb region downstream from the operon (See Table 2). In
these reactions, primers were designed to create 25-bp regions of complementarity between
the 3’ end of the upstream region and 5’ end of the aad9 cassette, and between the 3’ end
of the aad9 cassette and the 5’ end of the downstream region. A fourth PCR using primers
comCDEup1 and comCDEdn6 fused the three PCR products. All reactions were
performed using a high-fidelity polymerase Supermix (Invitrogen). The 2.5-kb PCR fusion
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product was column-purified (Qiagen, Inc. Valencia, CA) and used to transform SK36,
with Sc selection. DNA sequencing confirmed that the mutant, JFP49, contained the
desired comCDE deletion and Scr cassette insertion, and had no mutations within the
flanking regions.
comX
The comX gene was replaced with the Knr cassette aphA-3 (144) using a novel,
long-primer approach. Briefly, the aphA-3 gene was amplified with using 90-nt primers,
comXkanF and comXkanR, (See Table 2).constructed to possess 15-nt 3' ends
complementary to aphA-3 and 75-nt 5' ends complementary to the regions immediately
upstream and downstream of comX. The PCR product was purified as above and used to
transform SK36, with selection for Knr. DNA sequencing confirmed that the mutant,
JFP45, contained the desired cassette insertion and no mutations within the flanking
regions.
comXcomC
A comXcomC mutant was constructed by amplifying the mutant comX locus from
JFP45 cells with comXcomCF3 and comXcomCR4 to create a PCR product containing the
aphA-3 cassette and approximately 200 bp of upstream and downstream flanking
sequences amplified from the chromosome. The product was then purified and used to
transform the comC mutant, JFP41. DNA sequencing confirmed that the mutant, JFP60,
contained the desired cassette insertion in place of comX and no mutations within the
flanking regions.
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SSA_1889
Mutagenesis of SSA_1889 was performed similarly to the comCDE mutation,
where the products of three separate PCR reactions were combined. 1889up1 and 1889dn2
were used to amplify the 0.9-kb region upstream of SSA_1889, the 1889up3 and 1889dn4
primers amplified the aad9 (101) cassette, and the 1889up5 and 1889dn6 amplified the
0.9-kb region downstream of SSA_1889. In these reactions, primers were designed to
create 25-bp regions of complementarity between the 3’ end of the upstream region and 5’
end of the aad9 cassette, and between the 3’ end of the aad9 cassette and the 5’ end of the
downstream region. A fourth PCR reaction using 1889up1 and 1889dn6 fused the three
products together. The 2.5-kb PCR fusion product was column-purified (Qiagen, Inc.
Valencia, CA) and used to transform SK36, with Scr selection. DNA sequencing confirmed
that the mutant, JFP65, contained the desired SSA_1889 deletion and Scr cassette insertion,
and had no mutations within the flanking regions.
A double SSA_0195 and SSA_1889 mutant, JFP61, was also constructed by
transforming Ssx_0195 (23) (Knr) with the 2.5-kb purified PCR product used for JFP65
construction with Scr and Knr selection.

Additional Mutant strains
Strains listed in Tables 3 and 4 were obtained from the laboratory of Dr. Ping Xu
(Xu, et al manuscript under review) in BHI containing 500 μg/ml Kn (BHIKn500) and
frozen in 30% glycerol and stored at -80°C. Each mutant was constructed using overlap
extension PCR (65) to replace the respective ORF with the kanamycinR cassette aphA-3
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(144). In these mutants, the first 6 and last 30 base pairs of the respective ORFs were
maintained to sustain expression of flanking genes.

Creation of a construct for controlled expression of SSA_0195
The SSA_ 0195 gene was placed under the control of the isopropyl-beta-Dthiogalactopyranoside (IPTG)-inducible promoter Pspank (17, 158) within plasmid pDR110
(a kind gift from David Rudner, Harvard Medical School, Boston). Directional cloning
was used to insert PCR-amplified SSA_0195 and its native RBS into vector pDR110 via
unique 5’ SalI and 3’ SphI sites to create pJFP93. An EcoRI/BamHI fragment containing
the Pspank promoter, SSA_0195, and lacI from pJFP93 was ligated into the EcoRI/BamHI
sites of the E. coli-streptococcal shuttle vector pVA838 (100) to create pJFP94. pJFP94
was used to transform Ssx_0195 and JFP41, employing selection for resistance to Kn plus
Em or Em, respectively. To monitor the effect of SSA_0195 gene-overexpression, IPTG
was added at concentrations ranging from 0 to 1000 μM.

comXcomC electroporation with pJFP94 and pVA838
Electroporation of the comXcomC mutant was performed as previously described
for Streptococcus parasanguinis (42) with modifications. An overnight culture of JFP60
was diluted 1:10 in TH broth and grown to OD660 ≈ 0.9. The culture was then harvested by
centrifugation and resuspended in 10 ml 0.625 M sucrose, 10mM Tris-Cl, pH 6, followed
by an additional centrifugation and resuspension in 1 ml 0.625 sucrose 10mM Tris-Cl,
pH5. An additional centrifugation occurred at 4° C followed by resuspension in
28

electroporation buffer (1 mM Tris-Cl, pH5). 50 µl aliquots of cells plus DNA (20 ng
pJFP94 or pVA838) were electroporated in a 0.2 cm cuvette in a BioRad Gene Pulser set at
2.5 kV, 25 mFD, 200 Ω. Cells were immediately transferred to recovery media (TH broth
supplemented with 0.625 M sucrose) and incubated for 2h at 37°C. Cells were plated
employing selection for resistance to Kn plus Em.

29

Table 2. Primers used in this study for mutant generation
Nucleotide sequence ( 5' to 3')a
CCTCCTTGAATTACAATTGATG
GGATCCACTAGTTCTAGAGCGGAACTATCTCCTATCTTTTTATCTT
AAGATAAAAAGATAGGAGATAGTTCCGCTCTAGAACTAGTGGA
TTCCATTATATCAGGTTTCAATTTTTTTATAATTTTTTTAATCTG
CAGATTAAAAAAATTATAAAAAAATTGAAACCTGATATAATGGA
AGCTGGCTATTTCAGTCAAAGTC
GAACACTCAAATCGCCAAATCT
GGATCCACTAGTTCTAGAGCGGCAGGATAAAAAATAATCCCTTAG
CTAAGGGATTATTTTTTATCCTGCCGCTCTAGAACTAGTGGATCC
GGATAAAAAATGACATTTCACAATTTTTTTATAATTTTTTTAATCTG
AGATTAAAAAAATTATAAAAAAATTGTGAAATGTCATTTTTTATCCC
TCAGACGCTGAAGCTCTTGCCTG
GCTTTTTAGAAGAAAGAGCCCACCTTGCTTTCTATTTACAGTAGAAT
TAAGTCAAGTAAATTTTAAGGAGGAACTAAGGGCCCGTTTGAT
comXkanR
TTTTTATTTAATAAAAAAACTTGATGCTCTAACCTGTTCTAGTAAAA
CAGAAATAAAGTCATCAAGTTTGTTCACCGAATTCTAGGTACT
comXcomCF3 TTTTTCTTGCTTTTATACTTCGC
comXcomCR4 CCACTGACAGATTTATTTCTCGT
0195SalIF
CGCGCGTCGACTAAGAGAAGAATGGAGAGAATA
0195SphIR
GGTACGCATGCCACAAGAAGACCTTATCTAGT
a
Restriction sites denoted in bold; SalI, GTCGAC; SphI, GCATGC

Primer
comCDEup1
comCDEdn2
comCDEup3
comCDEdn4
comCDEup5
comCDEdn6
1889up1
1889dn2
1889up3
1889dn4
1889up5
1889dn6
comXkanF
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Assessment of full length S. sanguinis ComC in competence induction
Full-length S. sanguinis ComC peptide (Fig. 2) was synthesized (Genscript) and
used for assessment of genetic transformation in JFP41 relative to S. sanguinis CSP. The
ComC peptide was added to a transformation reaction as described above at an equimolar
concentration to S. sanguinis CSP and compared to transformations with 220 ng/ml
synthetic CSP.

Growth studies
Growth in broth culture was monitored as previously described (156). Overnight
cultures of strains were diluted 100-fold into THHS ± 220 ng/ml CSP. Strains containing
plasmids pJFP94 or pVA838 were grown in THHS with Em and 125 µM IPTG ± CSP.
Two hundred microliters of diluted cells of each strain were added in quadruplicate to the
wells of a 96-well microtiter plate (Greiner). Growth at 37°C under ambient air was
measured as OD450 in a FLUOstar microtiter plate reader (BMG technologies) every ten
minutes immediately following orbital shaking. Values indicated were obtained from
subtraction of background wells.

Bioassay for CSP quantification
SK36 cells were grown to various culture densities in TH-BSA (97) from early
exponential to stationary and supernatant from each sample was collected following
centrifugation at 7000 X g for 10 min at 4°C and filtration through a 0.22 μm filter.
Supernatants were then added along with transforming DNA to comC mutant cells, which
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are incapable of producing CSP. Transformations performed with synthetic CSP were used
to create a standard curve for quantification of CSP in supernatant.

Isolation and mass determination of CSP from SK36 cultures
Isolation of CSP from culture supernatant was performed using modifications of a
previously described method used in S. pneumoniae (56). SK36 and control, JFP41, were
grown overnight in TH (0.15% BSA) (97). The next morning strains were diluted 1:200
and grown to OD660 of 1.10. Cells were then pelleted by centrifugation at 7000 X g for 10
min at 4°C and supernatant was filtered using 0.22 μm SteriCups® (Millipore). 20 ml
aliquots of the filtered supernatant were rocked for 18 hr with 40% (NH4)2SO4 at 4° C.
Precipitated proteins were then pelleted by centrifugation at 10,000 X g for 30 minutes and
dissolved in 1ml HPLC water (FisherBrand). Total protein concentration was determined
by Pierce assay and functionality of CSP within protein sample was tested by bioassay as
described above. Samples from both strains were sent to the Mass Spectrometry core
facility at Virginia Commonwealth University. They underwent 2-D dimensional analysis
with strong cation exchange fractionization and liquid chromatography mass spectrometry
using collision induced dissociation (CID) (107) in ion trap of the fractions. The sample
was searched against an S. sanguinis protein database, allowing for cleavage anywhere
within the ComC peptide.

32

High-throughput ABC exporter mutant competence assay.
For high throughput analysis of competence, microtiter plates containing frozen
stocks were thawed on ice and 2 μl of each strain was inoculated into 2 ml of THHS a
sterile polypropylene deep well plate (USA Scientific), sealed with Qiagen tape pads, and
incubated O/N at 37° C. The next morning all strains were diluted 1:200 (1.6 μl cells
added to 330 μl THHS) in duplicate deep well plates containing prewarmed THHS and
10ng of pJFP16, covered with Airpore Tape sheets (Qiagen) and incubated at 37°C. After
1.5 hr, 70 ng of CSP was added to one plate. Plates were then returned to 37°C for 5
additional hours to ensure cells reached the proper optical density for DNA uptake and
sufficient time for incubation with DNA. 10 μl of each strain were then added to deep well
plates containing 990 μl BHI ± Cm, covered with Airpore Tape sheets and incubate at 6%
O2. The following morning growth was measure at OD450 in a FLUOstar microtiter plate
reader (BMG technologies). Media background was subtracted and mean OD450 for each
strain was measured.

Rabbit model of infective endocarditis
Virulence assays were performed using a modification of a previously described
rabbit aortic valve endocarditis model, using male specific pathogen-free New Zealand
White rabbits weighing from 3 to 4 kg (34). All protocols were performed in accordance
with Institutional Animal Care and Use Committee, and in compliance with all federal
guidelines and institutional policies. Prior to surgery, animals were sedated with
acepromazine, anesthetized with a cocktail of ketamine, xylazine, glycopyrrolate, and
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buprenorphine, and injected with bupivacaine at the incision site. A catheter was then
inserted over the aortic valve via the right carotid artery to induce vegetation formation
(34), as described previously (25, 47, 122, 156, 157) The catheter was then sutured and
kept in place for the remainder of the study. All efforts were made to ameliorate suffering
of animals at all stages of the experiment. Buprenorphine was provided as analgesia twice
daily throughout the study.

Competitive index analyses in the rabbit model of IE
To prepare inocula, bacterial strains were grown for 18 hours in BHI, and diluted
10-fold into BHI for an additional 3 h of growth at 37° C. Cells were then harvested,
washed in PBS, and diluted to the appropriate cell density, followed by inoculation of 0.5
ml into a marginal ear vein. Inoculations were performed two days post-catheterization.
Dilutions of the inocula were drop-plated onto BHI agar, with selective antibiotic when
required, and enumerated. After specified infection periods, rabbits were euthanized by
intravenous Euthasol (Virbac AH, Fort Worth, TX) injection. Vegetations, which were
readily identified as rough nodules or masses, were collected at pre-determined times from
aortic valves and endocardium and homogenized in PBS. Dilutions were drop-plated for
bacterial enumeration.
During competitive index (CI) experiments, JFP45 or JFP49 was co-inoculated
with an Emr derivative of SK36, JFP36 (156), and the strains were co-cultured for 3 h prior
to washing and suspension in PBS, as described above and plated on selective antibiotics.
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The CI value for each rabbit was calculated as the ratio of mutant/JFP36 in the vegetation
homogenate divided by the mutant/JFP36 ratio in the inoculum.
Individual inoculum analyses in the rabbit model of IE
For experiments employing inoculation of individual strains, inocula were prepared
as described above, except that strains were cultured individually, randomized for
individual inoculation into four catheterized rabbits each, and sonicated prior to inoculation
at 50% power for 3 minutes using a titanium cup adapter (BioLogics Inc.) Following
sonication, cells were adjusted to an OD660 value determined previously to correspond to
108 CFU/ml. During the course of infection, rabbits were weighed daily.
Five days post-inoculation, ~ 10 ml of blood was drawn from an ear artery of
surviving rabbits using a blood collection set (BD, Franklin Lakes, N.J.; cat. no. 368653)
and blood culture tubes containing 1.7 ml of 0.35% sodium polyanethol sulfonate solution
(BD; cat. no. 364960). Rabbits were immediately sacrificed, necropsy was performed, and
valve vegetations were weighed prior to homogenization and sonication. Density of
infection was determined as CFU/g of vegetation. Blood densities were determined by
mixing 10 μl to 1 ml of blood with 20 ml 1% low-melting agarose in BHI, which was then
poured into Petri dishes, allowed to harden, and incubated for two days at 37°C prior to
counting of colonies on triplicate plates. Blood density values were corrected to account
for the added sodium polyanethol sulfonate. The entire experiment was then repeated on a
separate occasion, and the results combined.
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Assessment of biofilm formation with crystal violet staining
The crystal violet (CV) biofilm assay (118) was performed as previously described
(47), with minor modifications. Briefly, cells were grown in BHI with respective
antibiotics overnight. Cells were then diluted 1:10 into pre-warmed BHI for 3 hours of
additional growth, followed by transfer of 1 µl to individual wells of 96-well polystyrene
microtiter plates (Greiner) containing 100 µl Biofilm Media (BM) (SAFC Biosciences,
Lenexa, KS) supplemented with 1% sucrose ± 220 ng/ml synthetic S. sanguinis CSP.
Biofilms then developed for 20 hours with no shaking anaerobically. Planktonic cells were
then decanted from wells, and biofilms were rinsed twice with 200 µl sterile distilled
dH2O. Plates were then dried at room temperature. Twenty-five µl of 1% (w/v) crystal
violet (CV) was added to each well and incubated for 15 min. The plates were then washed
three times with 200 µl dH2O. The stain was solubilized in 30% (v/v) acetic acid and 125
µl was transferred to a new microtiter plate where absorbance was read at 600 nm. The
OD600 was determined as the mean ± SD from three independent assays, with each strain
tested in quadruplicate wells. To examine the role of extracellular DNA during biofilm
formation, DNase I (Sigma) was added to the BM media immediately prior to inoculation.

Confocal Laser Scanning Microscopy (CLSM)
Strains were grown as for CV staining except that COSTAR 60-mm polystyrene
plates (Falcon-Primaria) were used in place of microtiter plates, and volumes were
adjusted proportionally. At 20 h, planktonic cells were removed and biofilms washed twice
with sterile dH2O. Biofilms were then stained for 15 min with a 1:1000 dilution of
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Invitrogen LIVE/DEAD® BacLightTM bacterial viability reagent, containing SYTO9 and
propidium iodide; stain was then removed and biofilms were covered with sterile dH2O.
Biofilms were visualized using a 40x water-immersion dipping objective on a Zeiss LSM
510 META confocal laser scanning microscope. Excitation wavelengths used were 488 nm
for SYTO 9 and 561 nm for PI. Images were examined using LSM image software (Carl
Zeiss).

Scanning Electron Microscopy (SEM)
Biofilms were prepared as for CLSM, except that a glass coverslip (Fisherbrand)
was immersed in the COSTAR 60-mm polystyrene plates. After 20 h, the coverslips were
rinsed in sterile water and fixed in 2% glutaraldehyde in 0.1 M cacodylate buffer (cb),
followed by fixation with 0.1% osmium tetroxide and an additional rinse in cb.
Dehydration was performed with a series of ethanol rinses at 50%, 70%, 80%, 95% and
100% followed by three hexamethadisilizane changes. Samples were dried in fume hood
and mounted on SEM stubs with silver paint, allowed to dry overnight, and gold coated 2-3
times prior to viewing. Samples were viewed on a ZEISS EVO 50 XVP Scanning Electron
Microscope.

Quantitative RT-PCR of SSA_0195
JFP41 was grown to an OD660 ≈ 0.070 in THHS. 12.5 ml of culture was mixed with
Twenty five mls of RNAprotect (Qiagen) and vortexed briefly. CSP was added to the
remaining culture at a concentration of 220ng/ml. Additional samples were collected at
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2.5, 5, and 15 minutes post-CSP induction and similarly mixed with a 2 volumes of RNA
protect. Extraction proceeded as described in the manufacture’s protocol for gram positive
bacteria with a few modifications. After stabilizing cultures in RNA protect cultures were
incubated for five minutes at room temperature and centrifuged for 20 minutes at 8,000 x g
for 20 minutes. The resulting pellet was resuspended in 100µl of TE buffer containing 15
mg/ml lysozyme and 2 mg/ml proteinase K and incubated with frequent vortexing for 30
minutes. After addition of lysis buffer, cells were lysed at a setting of 6 for two cycles at
55 seconds each in lysing matrix B (MPBio) using a beadbeater (MPBio) followed by
purification via the Qiagen RNeasy Mini Kit, during which Dnase I treatment occurred for
30 minutes over RNeasy Columns (Qiagen). Samples were quantified at 260 nm and
samples with a 260/280 ratio >2.2 or <1.8 were discarded. RNA samples were stored at -80
°C. Samples were further analyzed using an Experion TM Chip (Biorad) and RNA was
stored at -80°C. Additional treatment to remove genomic DNA was performed with
TurboFree (Ambion) using manufacturer’s instructions.
First strand cDNA synthesis occurred in a 20 µl reaction using 1.1µg total RNA
annealed to 250 ng random primers and incubated with 10mM dNTP mix for 5 minutes at
65 °C. Brief centrifugation of the tube was performed and First Strand Buffer (Invitrogen),
1 µl 0.1 M DTT, 1 µl RNAse OUT (Invitrogen) and 1 µl Super Script III Reverse
transcriptase (200 units/µl) (Invitrogen) were added. The mixture was gently pipetted up
and down incubated for 5 minutes at 25°C, followed by sixty minute incubation at 60 °C.
Reactions lacking reverse transcriptase were also prepared simultaneously to test for
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genomic DNA contamination. Inactivation of reverse transcriptase proceeded for 15
minutes at 70°C.
qRT-PCR reactions were performed using a 7500 Fast RT-PCR system (Applied
Biosystems). 10 μ qRT-PCR reactions were carried out in a using Real- TimeTM SYBR
Green/Rox PCR master mix (SuperArray) and internal designed primers in list appendix.
SSA_0195 was selected for RT-PCR quantification to The gapA gene was used for
normalization. A standard curve for SSA_0195 and gapA was generated using serial
dilutions of DNA templates of known concentration. Values were then normalized and
relative expression levels were determined through comparison of mean quantity of
transcript levels to control.

Statistical Tests
All statistical tests were performed using InStat (GraphPad Software Inc.), with α =
0.05. Actual P values are indicated in the text and figure legends. For virulence assays,
log-transformed CI values were compared to 0 using a one-sample t test. Strain recoveries,
infection densities, vegetation masses, and weight loss for each strain group were
compared using one-way ANOVA. Survival rates were compared by Kaplan-Meier
analysis. Significance of differences in CV staining, culture densities, transformation
assays, and CSP viable counts were assessed using paired t tests.
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CHAPTER 3: CHARACTERIZATION OF GENETIC
COMPETENCE IN STREPTOCOCCUS SANGUINIS

RATIONALE
Despite the apparent absence in S. sanguinis of the comA, comB, and comW genes
(168), physiological studies and global expression analyses have demonstrated that S.
sanguinis competence and com gene regulation are similar in most respects to that of S.
pneumoniae (136). Microarray studies performed with a comC mutant suggested
upregulation of 124 genes in S. sanguinis in response to CSP (136). In S. pneumoniae
(131) microarray analysis identified a similar, though non-identical set of CSP-upregulated
genes. Among the major differences observed were the significantly fewer “early” genes
within S. sanguinis (136). Early response com genes identified in S. sanguinis by
microarray were comCDE and comX, and a previously uncharacterized gene, SSA_1889.
The “late” genes identified were representative of those seen in other studies (131, 136,
161). In contrast to the other streptococci, the sequence of the S. sanguinis ComC peptide
is unique in that it lacks the Gly-Gly motif that serves as the site of cleavage for CSP
formation in other ComC peptides. Additionally, the secretion apparatus has not been
identified. Here we seek to further characterize features of the S. sanguinis com regulon
including functions of the early and late com genes, and mechanisms of ComC processing.
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RESULTS
Creation and verification of early com mutants in S. sanguinis
To examine possible functions of the S. sanguinis com regulon, we first sought to
create mutations in key regulatory genes. We used an overlap extension PCR technique
(65) to fuse a Scr cassette to ~1 kb of DNA on either side of the comCDE operon.
Introduction of this construct into SK36 resulted in the replacement of the comCDE genes
with the Scr cassette, creating mutant JFP49. (See Table 1 for strains and Table 2 for
primers.) Mutation of the comX gene by the same strategy was problematic because the
gene is closely flanked by tRNA genes on one side and a 16S rRNA gene on the other
(168). To avoid transforming with a construct containing these repetitive sequences, we
attempted the novel approach of amplifying a Knr gene (144) with PCR primers designed
with 75-nt 5’ ends complementary to comX-flanking sequences, and then introducing the
purified product into SK36 by transformation. Although the transformation efficiency was
low, we succeeded in isolating a mutant, JFP45, in which the comX gene was replaced by
the Knr cassette.
We then tested both mutants and a comC mutant in transformation assays in the
absence and presence of S. sanguinis CSP. The transforming DNA, plasmid, pJFP16, (Fig.
3A) is a suicide plasmid encoding a chloramphenicol acetyltransferase (cat) gene within a
mini-transposon flanked by approximately 1.9 kb of DNA encoding and flanking the S.
sanguinis nrdD gene (156). We expected that a previously created comC mutant would be
incapable of CSP secretion and would only be transformed when synthetic CSP was added
to the media. This result was observed (Fig. 3B), lowering the frequency from 11% in the
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presence of CSP to below the limit of detection in the absence of CSP (3.6% X 10-5 %).
We expected that the comCDE mutant would not undergo transformation in either the
presence or absence of added synthetic CSP, as loss of the CSP sensor and its cognate
response regulator would not be overcome by the addition of CSP (131). As expected,
mutation of comCDE drastically reduced or eliminated transformation (Fig. 3), lowering
the frequency from 12% in SK36 to below the level of detection (1.3 X 10-5 %) in JFP49 in
both the presence and absence of CSP. Similarly, we expected a comX mutant to exhibit
little or no competence in the presence or absence of CSP, as the sigma factor it encodes is
required for upregulation of DNA uptake genes in other species (131). Comparable results
were obtained; deletion of comX lowered the transformation frequency from 12% in SK36
to below the limit of detection (7.7 X 10-5 %) in JFP45, in the presence or absence of CSP.
The combined results suggest that these four genes function in S. sanguinis competence
regulation indistinguishably from their counterparts in S. pneumoniae (131), S. gordonii
(161), and other Mitis group species (102).
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Figure 3. Transformation of strains possessing mutations in early com genes
A. Plasmid map of transforming DNA, pJFP16 (Reproduced with permission)
B. S. sanguinis strain SK36 and its isogenic mutants were assayed for transformation
frequency defined as the ratio of Cmr transformants to total colony forming units (CFUs).
Shown are the transformation frequencies ± SD of three independent experiments.
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Identification of SSA_0195 as an early gene
A previous microarray study (136) in this lab performed with the comC mutant,
JFP41, revealed an additional gene that exhibited kinetics consistent with early gene
expression, appearing upregulated by CSP more than 15-fold at 2.5 min and more than
four-fold at all later time points, but failed the significance test due primarily to
undetectable expression at time 0 (Fig. 4). Expression of this gene, SSA_0195, was
therefore examined by quantitative RT-PCR, using gapA for normalization. SSA_0195
expression at time 0 was barely detectable. In comparison, mean normalized log2 values
for expression of SSA_0195 at 2.5, 5, and 15 min post-CSP addition were 32.6, 36.1, and
30.6, respectively, indicating strong and rapid induction. Inclusion of SSA_0195 along
with the missing comC gene suggests a total of six early genes: comCDE, comX,
SSA_1889, and SSA_0195.
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Figure 4. Colorimetric map of S. sanguinis early com genes
(Reproduced with permission)
Each column represents the time point indicated above, and each row the expression of a
single gene relative to the “0” time point, as measured by microarray analysis. Levels of
gene upregulation in response to CSP are indicated by colors varying from black (<2 fold)
to bright red (>32 fold). Gray squares indicate incomplete data. Genes in red text are
homologs of early competence genes from S. pneumoniae.
A. Represents initial analysis.
B. Represents final analysis after significance test. SSA_0195 was filtered out due to
extremely low expression at T0.
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Screening of early genes as potential ComC exporters
Because no comAB-like genes were identified during sequencing (168), one goal of
this study was to identify orthologs (or analogs) of the S. pneumoniae ComA and ComB
CSP transporters. Based on the finding that both are encoded by “early” genes in S.
pneumoniae (131) and S. gordonii (161), this lab originally used a transcriptome analysis
for this search. As mentioned above, microarray and RT-PCR revealed six “early” genes
whose expression was upregulated at least 4-fold at 2.5 minutes post-CSP. Three were
known early com genes: comD, comE and comX. The two additional genes were
SSA_0195 and SSA_1889. Both genes encode hypothetical proteins. SSA_1889 is
annotated as a conserved uncharacterized protein. Apart from alleles in other S. sanguinis
genome-sequenced strains, its closest match in GenBank is a hypothetical protein from S.
anginosus (ZP_08014095.1). SSA_0195 is annotated as a hypothetical protein whose
closest matches are also alleles from other S. sanguinis strains, followed by a hypothetical
protein from Streptococcus cristatus (ZP_08059937.1). Both proteins have weak
homology to the CAAX family of N- terminal proteases, (124) yet possess no significant
similarity to each other. We hypothesized that one or both of these was involved in CSP
secretion or otherwise required for genetic competence. SSA_0195 and SSA_1889 mutants
and a double mutant were constructed by an overlap extension PCR technique (65) and
tested for competence, using pJFP16 as described. We would expect that a transporter
mutant would be severely reduced for transformation, except in the presence of exogenous
CSP. However none of the three mutants exhibited a greater than two- fold reduction in
transformation in either the presence and absence of CSP, suggesting that neither gene
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encodes a CSP transporter or any other function critical for transformation (data not
shown).

Assessment of “late” com genes in S. sanguinis
We next assessed competence in orthologs of late genes identified in S. sanguinis
(168) found previously to be required for transformation in S. pneumoniae (131). Many of
these genes were identified in a previous microarray study within our lab, to be
upregulated in response to CSP (136). However, this study failed to identify the
upregulation of 5 orthologs of late genes found previously to be required for
transformation in S. pneumoniae. We next wished to determine if this was due to a
fundamental difference in transformation machinery in the two species. We took advantage
of an existing collection of SK36 allelic exchange mutants in which genes were replaced
by the aphA-3 gene encoding kanamycin resistance (Xu et al., manuscript in preparation)
to test the effect on the transformation efficiency of mutating 15 genes that were either
orthologs of genes essential for transformation in S. pneumoniae, or were located in the
same gene cluster. Those tested included orthologs of each of the 5 genes whose
upregulation was not detected. Transformation was assessed in SK36 and the mutants as
above, except that the incubation with CSP and DNA was begun at a lower OD and
extended to two hours for increased sensitivity, and surface plating was used. The results
are presented in Table 3 and were comparable in comparison to their orthologs in S.
pneumoniae (131).

49

Table 3. Assessment of competence in late com orthologs in S. sanguinis
Orthologs of putative “late gene” mutants in S. sanguinis were assessed for
competence. Gene list indicates allelic mutants. % of WT is transformation
frequency of mutant divided by transformation frequency of SK36. Each gene is
listed in the same row as its S. pneumoniae ortholog, and competence in S.
pneumoniae mutant strains determined previously is listed (131). In S.
pneumoniae, transformation in mutant is indicated as “Y” for yes or “N” for no.
Percentage indicated equals percent of WT.
This experiment was performed in triplicate and mean frequencies are indicated.
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Table 3.

Consideration of potential ComA-independent ComC secretion mechanisms in S.
sanguinis
As discussed, sequencing of S. sanguinis revealed a unique ComC (Fig. 2)
sequence with no ComA ortholog or analog identified through DNA sequencing or
microarray analysis (136, 168). We next considered the possibility that ComC is exported
without cleavage in S. sanguinis, perhaps by a non-specific transporter. If this were the
case, we might expect full-length ComC to have greater competence-stimulating activity
than our CSP peptide. A full-length ComC peptide was synthesized by GenScript. Genetic
transformation of the comC mutant was tested as described above using pJFP16 ± 70 ng
CSP, or an equimolar concentration of full-length ComC. As seen in figure 5, we observed
15-fold greater transformation frequencies using CSP compared to the full-length peptide.
These results, though far from conclusive, suggest that ComC is cleaved in S. sanguinis.
Finally, we also considered the possibility that ComC is processed through the
standard Sec-dependent pathway. Several bacteriocins have been shown to be similarly
processed (64, 89), However, in contrast to these bacteriocins, which have typical signal
peptide sequences, analysis of ComC by SignalP 3.0 (36, 116) identified no hint of a signal
sequence (Fig.6) and classified this peptide as a non-secretory protein.
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Figure 5. Transformation comparisons of full length ComC and processed CSP
JFP41, the comC mutant, was assayed for transformation frequency using the standard 70
ng of synthetic CSP or an equimolar (162 ng) full length ComC peptide.
* indicates significant variation from full length peptide transformation frequency (P <
0.0001).
Shown are the transformation frequencies ± SD of two independent experiments.
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Figure 6. SignalP Cleavage Prediction analysis of:
(A) Lactococcus lactis bacteriocin lactoccin, where cleavage is predicted to occur between
amino acid positions 25 and 26
(B) S. sanguinis ComC
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Figure 6. SignalP Prediction for:
A. Lactococcus lactis bacteriocin lactococcin

B. S. sanguinis ComC
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Determination of ideal culture density for CSP isolation
Given the possibility that ComC is cleaved to CSP when exported, we next wished
to determine the sequence of secreted SK36 CSP. We first determined that BSA could
replace horse serum in TH-HS without decreasing the transformation efficiency of the
SK36 strain (data not shown). BSA has been used previously as a substitute for serum in
streptococcal transformation (97) and will likely contain fewer peptides that could interfere
with CSP isolation (Gunnar Fimland, personal communication). To determine the culture
density containing the greatest amount of CSP, SK36 cells were grown to various culture
densities in TH-BSA, and culture supernatant from each sample was collected following
centrifugation and filtration through a 0.22 μm filter. 20 μl from each supernatant were
then added along with pJFP16 to JFP41, comC mutant cells, which are incapable of
producing CSP. As a control, supernatant from a comC mutant was similarly added and did
not induce competence (data not shown). Although transformation efficiency of SK36
peaks at an OD660 of ~ 0.07, (136) Fig. 7 shows that the culture supernatant from stationary
phase cells had much higher levels of competence-stimulating activity than cultures
harvested during the peak of competence. Transformations were then performed with
synthetic CSP to create a standard curve to quantify CSP in supernatant. Using linear
regression we determined there was approximately 1.2 ng of CSP in each μl of supernatant
taken from a culture with an OD660 of 1.1.
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Figure 7. Competence induction in a comC-deficient strain using SK36 culture
supernatants or synthetic CSP
A. SK36 supernatants were collected at various densities and 20 μl used to induce
competence in a comC-deficient strain incubated with transforming DNA (pJFP16). A
representative experiment of three separate experiments is shown.
B. Standard curve created by adding known concentrations of synthetic CSP to induce
competence in a comC-deficient strain incubated with pJFP16. A representative experiment
of three separate experiments is shown.
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Isolation of CSP from competent SK36 supernatant
To increase the concentration of CSP in our sample, we next used ammonium
sulfate precipitation of total secreted proteins. Preliminary experiments tested the
transforming ability of centrifuged, filtered SK36 supernatants precipitated with 40% to
70% (NH4)2SO4, and determined 40% contained the greatest amount of functional CSP.
JFP41 was similarly treated and its culture supernatant did not induce competence (data
not shown). The precipitated culture samples from each strain were then dissolved in
HPLC grade water, resulting in a final concentration of 20-fold.
Each sample then underwent 2-D dimensional analysis with strong cation
exchange fractionization followed by liquid chromatography mass spectrometry (LC-MS)
using CID fragmentation of the fractions. The samples were then searched against an S.
sanguinis protein database, allowing for cleavage anywhere within the ComC peptide. No
matches were identified in the JFP41 sample. The practical fractionization spectra for
SK36 is illustrated in Fig. 8. The identified secreted CSP had a +3 charge, with the original
peptide mass to charge ratio identified at 590.6484 corresponding to a mass of 1769.92.
Post-experiment Monoisotopic Mass Filtering (139) analysis determined the peptide mass
matched to 3.3 ppm accuracy. However, as seen in Fig. 8, using CID fragmentation often
results in loss of the parent mass within the spectrum. There is, therefore, a hole in the
spectrum occurring around 590 m/z (Kristina Nelson, personal communication). Sequest
analysis (39) was also performed, and determined a match corresponding to the last 15
amino acids of ComC (DLRGVPNPWGWIFGR) (Fig. 9) with a cross-correlation (XCorr)
value of 3.85, indicating a very good match.
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Figure 8. Practical fragmentation spectra of SK36 CSP
Practical fragmentation spectrum using collision induced dissociation of Liquid
Chromatography Mass Spectrometry of secreted CSP from SK36
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Figure 8.

Figure 9.Theoretical fragmentation spectra of S. sanguinis CSP
Theoretical fragmentation spectra using Sequest analysis of peptide sequence. Masses
indicated represent singly charged fragments and predict the sequence of amino acids
within analyzed peptide.
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Figure 9.

Candidate exporter selection and screen
As discussed, ComA in other streptococcal species serves a dual function involving
removal of a leader peptide from its substrate and transport across the plasma membrane.
Findings so far within S. sanguinis suggest processing of ComC during transport; however,
the mechanisms and the identity of the transporter remain uncharacterized. Further,
microarray data suggested that the ComC exporter is not specifically up-regulated in
response to CSP as in S. pneumoniae. We next considered the possibility that ComC is
transported by an ABC exporter whose principle function is secretion of another small
peptide or drug. Because ComA is capable of concomitant transport and cleavage (57), we
next identified candidate systems possessing strong homology to this protein. Within the
genome of SK36 there are a total of 147 ABC transporters. Of these, the 26 ABC export
systems listed in table 4 were selected as candidates that exhibit homology to systems
capable of peptide and drug export. These systems were conserved in BlastP (5) searches
of the SK36 genome against ComA of several S. pneumoniae strains, S. gordonii, NisT
(40) and SpaT (76). NisT and SpaT are ABC transporters that transport nisin and subtilin,
respectively, two bacteriocins lacking a double glycine cleavage signal, which is also
missing in ComC. Within such bacteriocin systems, the transporter is often encoded on the
same or nearby operon as the peptide. Prior to the microarray study, previous work in the
lab began this screen, noting such proximity. SSA_2249, which exhibits homology to the
ATPase component of small peptide transporters, was first tested as a potential ComC
exporter. This transport system is located two genes away from recA and cinA, two
essential genes for transformation which are ComX dependent in S. pneumoniae (131). A
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mutant was assayed for transformability. However, it was readily transformable in both
the presence and absence of synthetic CSP. We next continued our search of the exporter
by testing genetic competence in all knockouts of these candidate systems.
The candidate ABC permease and ATPase genes chosen were selected based upon
putative transport classification (168) using the transport classification database
(TCDB.org) (137). The types of exporters chosen exhibited strong homology to ABC-type
transport systems which export lantibiotic bacteriocins (which lack a GG signal), nonlanthionine bacteriocin (which contain GG cleavage motifs) (70) exporter systems
involved in drug efflux and lastly, the alpha and beta toxin exporters. SSA_1100 is
classified as an alpha-hemolysin exporter exhibiting the highest alignment scores of the
ComA protein of S. pneumoniae, S. gordonii, and S. mutans against the SK36 genome.
To determine if ComC is transported by an ABC exporter whose principle function
is secretion of another small peptide or metabolite, we screened an existing mutant library
for strains possessing the expected phenotype of a transport mutant, growth in Cm when
provided pJFP16 in the presence of synthetic CSP, but not when CSP is omitted. As
before, strains were obtained from the laboratory of Dr. Ping Xu, where the respective
ORFs were replaced with an aphA-3 Knr cassette. The candidate systems selected
encompassed approximately 60 genes and are shown in Table 4.
This screen began by using plate transformations assays as described above, and
mutants of SSA_1100, SSA_0201, SSA_0407, and SSA_0412 were tested that way, all of
which were transformed in both the presence and absence of CSP (not shown). To
increase the number of mutants that could be tested at one time, we then employed a high66

throughput liquid transformation assay as described in the methods. SK36 and JFP41 ±
CSP were simultaneously tested as controls for wild-type and mutant competence,
respectively. The results of this screen are demonstrated in Fig. 10. All strains grew in the
presence of BHI (not shown). As seen in Figure 10, JFP41 gave rise to Cmr transformants
when incubated with transforming DNA in the presence of exogenous CSP but not in its
absence. In contrast, SK36, which is capable of producing its own CSP, produced Cmr
transformants in both the absence of presence of CSP. Neither strain was able to grow in
Cm in the absence of DNA. The results of this high throughput analysis are shown in Fig.
10, and indicate none of the mutants screened exhibited the desired phenotype of ComC
exporter. Strains exhibiting variability in overnight optical density in media containing Cm
between ± CSP incubations were further tested individually using plate transformations.
However such analysis did not reveal any mutant with the desired phenotype (not shown).
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Table 4. Candidate ComC export systems
S. sanguinis ABC export systems selected to screen for processing and secretion of the
propeptide ComC to the mature quorum sensing signal, CSP. Classification of these
systems within SK36 is putative and based on strong homology to systems described in the
Transport Classification Database (TCDB.org). Those systems listed exhibit strong
homology to: the lantibiotic bacteriocins exporters, the non-lanthionine bacteriocin
exporters, the drug efflux systems and alpha and beta toxin exporters. Table 4 is split into
A and B for clarity of presentation.
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Table 4 A.
Gene ID
SSA_0201
SSA_0202
SSA_0203
SSA_0407
SSA_0408
SSA_0410
SSA_0411
SSA_0412
SSA_1766
SSA_1767
SSA_2010
SSA_2011
SSA_0393
SSA_0722
SSA_0723
SSA_0724
SSA_0725
SSA_0726
SSA_0727
SSA_0728
SSA_0442
SSA_0443
SSA_0461
SSA_0462
SSA_0607
SSA_0608
SSA_0796
SSA_0894
SSA_0895

Description
ABC multidrug transporter 3-component subtilin immunity exporter, putative
Conserved hypothetical protein, possible transmembrane
Conserved hypothetical protein, possible transmembrane
Multidrug ABC transporter, ATPase and permease components, putative
Conserved hypothetical protein
Conserved hypothetical protein
Conserved hypothetical protein
ABC multidrug transporter (3-component subtilin immunity exporter, putative
Bacitracin ABC transporter, permease protein, putative
Bacitracin ABC transporter, ATP-binding protein, putative
ABC-type multidrug transport system, permease component, putative
ABC-type multidrug transport system, ATPase component, putative
Bacteriocin ABC-type exporter, ATP binding/permease protein, putative
Conserved hypothetical protein, possible membrane-associated peptidase
Hypothetical protein
ABC-type multidrug/protein/lipid transport system (pediocin PA-1 exporter)
Hypothetical protein
FmtA-like protein, putative
Metal-dependent membrane protease, putative
Protease, putative
ABC-type multidrug transport system, ATPase component, putative
Possible ABC-type efflux pump permease component, putative
ABC-type multidrug transport system, ATPase and permease components
ABC-type multidrug transport system ATPase and permease components
ABC transporter, permease component, putative
Macrolide-efflux protein, putative
ABC-NBD transporters with duplicated ATPase domains, putative
ATP-binding cassette protein, putative
ATP-binding cassette transporter-like protein, putative
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Table 4 B.
Gene ID
SSA_0910
SSA_2165
SSA_2166
SSA_2167
SSA_0928
SSA_0929
SSA_1026
SSA_1087
SSA_1107
SSA_1109
SSA_1373
SSA_1374
SSA_1375
SSA_1376
SSA_1402
SSA_1403
SSA_1530
SSA_1531
SSA_1532
SSA_1636
SSA_1658
SSA_1659
SSA_1660
SSA_1679
SSA_1680
SSA_1681
SSA_1100
SSA_1904
SSA_1905
SSA_2376
SSA_2377

Description
ABC-type multidrug transporter, ATPase component, putative
ABC-type oligopeptide transporter, periplasmic component, putative
ABC-type multidrug transporter, ATPase and permease components, putative
ABC-type multidrug transporter, ATPase and permease components, putative
ABC-type multidrug transporter, ATPase and permease components, putative
ABC-type multidrug transporter, ATPase and permease components, putative
ABC-type multidrug transporter, ATPase component, putative
ABC-type transporter (antibiotic resistance protein), ATPase component, putative
Multidrug/protein-type ABC exporter, ATP binding/membrane-spanning protein
ABC transporter ATP binding/permease protein, putative
ATPase components of ABC transporters, multidrug transport system
Multidrug ABC transporter, ATPase and permease components, putative
Multidrug ABC transporter, ATPase and permease components, putative
Transport protein, putative
ABC-type multidrug transport system, ATPase and permease components, putative
Multidrug ABC transporter, ATPase and permease components, putative
ABC-type antimicrobial peptide transport system, permease component, putative
ABC-type antimicrobial peptide transporter, ATPase component, putative
Membrane-fusion protein / periplasmic component of efflux system, putative
ABC-type antibiotic exporter, ATPase component, putative
Cationic amino acid transporter, putative
ABC-type antimicrobial peptide transport system, permease component, putative
ABC-type antimicrobial peptide transport system, ATPase component, putative
ABC-type multidrug transport system, ATPase component, putative
ABC-type bacitracin resistance protein A, permease component, putative
ABC-type bacitracin resistance protein A, ATPase component, putative
HylB ATPase of the RTX toxin export system, putative
ABC-type multidrug transport system, permease component, putative
ABC-type multidrug transport system, ATPase component, putative
ABC transporter with duplicated ATPase domains, putative
ABC transporter, permease component (possible copper exporter), putative
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Figure 10. High throughput liquid transformation assay of candidate exporter
mutants
S. sanguinis SK36, JFP41 and exporter mutants were assayed for growth in BHI broth +
Cm following incubation with pJFP16 ± 220 ng/ml CSP. This experiment was performed
in triplicate and mean OD450 and SD values are indicated. Solid bars, no CSP; striped bars,
plus CSP. Fig. 10 is split into A and B for clarity of presentation.
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Figure 10 A.
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Figure 10 B.

DISCUSSION
Genetic exchange within oral bacteria may be very important for adaptability to this
environment which is constantly in flux. Further, there is evidence this process has worked
to shape the genome of S. sanguinis (168). This study attempted to further characterize
key components of the S. sanguinis com regulon. Our examination of DNA uptake in S.
sanguinis mutants of early regulatory genes comCDE and comX, taken together with
previous transcriptome analysis following CSP induction support a similar role of these
genes in DNA uptake. Two additional early genes, SSA_0195 and SSA_1889, did not
appear to play a role in DNA uptake, and will be examined for other functions. Analysis of
orthologs of late com genes identified within S. sanguinis also demonstrated these genes
function as in other competent streptococci. Taken together, the combined mutagenesis
transformation assays and previous transcription expression data from S. sanguinis, (136)
S. pneumoniae, (131), S. gordonii (161) and S. mutans (127) suggest a shared core regulon
of late genes required for transformation.
However despite these similarities to other competent streptococci, the com
regulon of S. sanguinis demonstrates unique and uncharacterized features. These relate to
the processing of CSP, the quorum sensing signal of this cascade. A main objective of this
study was to determine mechanisms of ComC cleavage and the sequence of secreted CSP.
Having determined that synthetic CSP induced competence in a comC mutant at levels 15fold greater than the full length uncleaved peptide, we next identified the sequence of
secreted CSP. Previous studies within S. sanguinis determined competence is dependent
on cell density and occurs in early exponential growth phase (OD660 ≈ 0.070) (136)
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followed by a rapid drop in competence, as in S. pneumoniae (56, 152). Our findings
indicated that as the culture density increased, the amount of active CSP within the media
increased as well. Although evidence exists that S. sanguinis cells are not active for DNA
uptake at intervals beyond 40 minutes after the onset of competence, or at densities greater
than 108 CFU/ ml (136) our findings suggest continued secretion of CSP at later cell
densities. This is in agreement with a recent transcriptome analysis performed within S.
sanguinis which indicated that although the comDE operon upregulation was highest at 5
minutes CSP post exposure; these genes did not reach basal levels at 30 minutes post
induction (136). Later waves of competence have also been observed within S. pneumoniae
(22).
Our findings of the cleavage site of ComC to CSP are in agreement with those
predicted by Havarstein (59), and indicated the ComC translation product begins as a 35
amino acid precursor with the C-terminal 15 amino acids corresponding to the biologically
active CSP with the sequence Asp-Leu-Arg-Gly-Val-Pro-Asn-Pro-Trp-Gly-Trp-Ile-PheGly-Arg. The 20 amino acids N-terminal leader peptide appears to be removed either
before, during, or after secretion of CSP from the cell, although no evidence of the full
length sequence was found during identification (Kristina Nelson, VCU Mass Spec Core,
personal communication). The sequence of the leader peptide does not appear to be related
to the N-terminal sequences required for transport of proteins across the membrane via the
Sec pathway. Further it does not appear to be closely related to those seen in the other
streptococcal species (Fig. 2) which possess a GG motif prior to cleavage. Within these
other species listed in Fig. 2 there are conserved hydrophobic residues at positions -4, -7, 75

12, and -15 (56). However, the leader peptide of S. sanguinis ComC only demonstrates the
presence of nonpolar amino acids within 2 of these domains -12 (Ala) and -15 (Phe). This
study determined cleavage occurs after the non polar FW motif prior to the + 1 Asp
residue, the presence of a +1 Asp this also seen in majority of species in figure 2. The
presence of FW as a potential cleavage signal does not appear to be a previously
characterized motif signaling peptide cleavage. However cleavage prior to Asp residues
can occur through activity of the Asp-N endopeptidases. Examination of S. sanguinis
ComC for predicted cleavage sites with ExPASY Peptide Cutter reveals a single cut at
position 20 just prior to the +1 Asp, using Asp-N endopeptidase. Activity of this gene was
demonstrated in Pseudomonas fragi (68); however neither a BLASTP nor a TBLASTN
search did not identify any related open reading frames within S. sanguinis.
In the experiments described above, it should be noted the CSP mass and sequence
determination were based upon separation and analysis of all secreted peptides from S.
sanguinis. Follow-up studies sought to create a purer fraction based of the size of the
analyzed peptide. Because CSP has a mass of 1.77 kDa, filtered competent SK36
supernatant was separated using 10 kDa size exclusion columns and the filtrate (<10kDa)
was tested for transformability with JFP41 as described above. However this did not
induce competence within JFP41. Further examination determined active CSP to be in the
retentate (> 10kDa), and a mixture of CSP and BSA (66 kDa) separated in the same
manner only induced competence in JFP41 when the retentate was added (data not shown).
Such findings suggest binding between CSP and BSA. This may explain why serum or
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serum albumin is known to be required (125) for streptococcal transformation. Future
studies are planned to determine the nature of this binding.
Within S. sanguinis, both previous sequencing (168) and transcriptome analysis
(136) failed to identify the CSP transporter. Our findings additionally suggest that CSP is
not exported by an ABC transporter demonstrating homology to ComA. This is not
surprising due to the unique sequence of the mature CSP peptide, and lack of well
characterized Gly-Gly motif. In S. pneumoniae (102, 131), S. mutans (52, 127) and S.
gordonii (161) bacteriocin production is linked to competence induction. In S. gordonii,
ComAB is also involved in the processing and secretion of bacteriocin-like peptides (61).
In S. mutans the genes originally proposed to process transport CSP were later shown to be
responsible for bacteriocin transport. However, use of a database mining program (26) with
S. sanguinis SK36 failed to reveal any strong bacteriocin candidates and putative matches
were included in the high throughput screen. Taken together, our findings suggest a unique
mechanism of peptide transport and processing in S. sanguinis that warrants further
investigation.
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CHAPTER 4: ASSESSMENT OF COM REGULATORY GENES IN S.
SANGUINIS ENDOCARDITIS VIRULENCE
RATIONALE
Roles for the streptococcal com regulon apart from genetic competence have been
postulated based on the finding in S. pneumoniae that all but 23 of the 124 upregulated
genes were individually dispensable for transformation (131). Previous studies of systemic
disease in S. pneumoniae (8, 55, 86) and caries formation by S. mutans (94) have indicated
that com regulon genes contribute to virulence in these species by mechanisms that are
likely unrelated to DNA uptake. Here we examine the effect of mutation in key regulatory
genes of the S. sanguinis com regulon, and their examination in a rabbit model of IE.
RESULTS
Examination of com regulatory gene mutants for IE virulence in competition assays.
Once we had confirmed that our com regulatory mutants had the expected
phenotypes (Chapter 3), we wanted to determine if the com regulon contributes to IE
virulence in S. sanguinis. We began by testing the comCDE and comX mutants by
competitive index (CI) assays in our standard rabbit endocarditis model (25, 47, 122, 156,
157). Catheterized rabbits were co-inoculated with 108 CFU of one of the mutants and
JFP36—an Emr derivative of SK36 that we have shown to be indistinguishable in multiple
traits, including growth rate, genetic competence, and virulence for IE (156). CI values for
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each rabbit are presented Fig. 11A. The comCDE mutant, JFP49, exhibited a mean CI
value of 1.44, suggesting a modest, though significant, increase in competitiveness
compared to the control strain, JFP36 (P < 0.05). The mean CI value for the comX mutant,
JFP45, was 1.05, which was not significantly different from 1 (P =0.71). The results
suggested that neither comCDE nor comX was required for IE virulence in our standard
assay.
Previous studies of IE in the S. gordonii rat model have demonstrated increased
sensitivity in competition assays when inoculum levels were reduced (147, 167). To
determine whether this might increase our ability to detect subtle changes in
competitiveness, we tested lower co-inoculum levels (105 and 106) of JFP36 and the
comCDE mutant in three rabbits each. The CI values for two rabbits from each group are
shown in Fig. 11B. In contrast to our previous results, these experiments revealed marked
variability in individual CI values at both inoculum levels. Indeed, CI values could not be
calculated for one rabbit in each group, due to a failure to recover JFP49 from a rabbit with
the 105 inoculum and JFP36 from a rabbit with the 106 inoculum. This variability is also
illustrated in Fig. 11C, which shows the number of JFP36 and JFP49 CFU recovered in
each experiment. As seen in Fig. 11C, the use of lesser inocula generally resulted in lower
and more variable recoveries of both strains, suggesting a bottleneck effect, whereby too
few cells establish infection to ensure accurate representation of each strain (63, 122, 157).
In contrast, use of a 108 inoculum resulted in highly reproducible recovery of both strains.
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Figure 11. Examination of com mutants in a competitive index model of rabbit
endocarditis at multiple inoculum levels.
Each symbol represents data from a single rabbit.
(A) CI values from rabbits inoculated with 108 CFU. Geometric mean CI values from the
combined results of two experiments are indicated in parentheses and by horizontal bars.
(B) CI values from rabbits inoculated with 105 or 106 CFU.
(C) Recovery of competing strains from infected vegetations at multiple inoculum levels.
Each pair of connected circles indicates recovery of JFP36 (filled circles) and JFP49 (open
circles) from the same rabbit. Data are from experiments depicted in panels A and B.
Dashed line, limit of detection; *, mean CI value significantly different from 1 (P< 0.05).
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Figure 11.
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Examination of com regulon mutants for IE virulence and pathogenesis by
individual inoculation.
Our finding that neither com regulatory mutant showed attenuation of IE virulence
prompted us to consider other modifications to our virulence assay. First, we considered
the possibility that strains might be affected by co-inoculation, with one strain producing,
for example, a trans-acting factor that had an effect on the other. This possibility could be
eliminated by inoculating mutant and control strains into separate animals. In addition, this
would allow for comparison of the pathology caused by each strain. We also considered
the possibility that a longer infection period would reveal a contribution of the com regulon
to virulence that was not apparent from the 20-h infection employed in our previous
assays. This, too, would represent a relevant condition, since streptococcal IE typically
progresses for days or weeks before detection and treatment (9, 108). Finally, we also
considered the possibility that virulence differences might be obscured by variation in
colony counts caused by chain length variation, as mutation of comX resulted in longer
chains relative to JFP36 (Fig. 12). If this were the case, we would expect two strains with
equal OD660 to have varying inocula with the strains with the longer chains resulting in less
CFU. We simultaneously tested all three possibilities by sonicating strains prior to
inoculation and after recovery from the animal to eliminate potential chain-length
differences, inoculating mutant strains and JFP36 into separate rabbits, and extending the
infection time to 5 days. A total of eight rabbits each were inoculated with 108 CFU of the
comCDE or comX mutants, or JFP36. The results are presented in Table 5. The total
number of CFU recovered from vegetations for each of the three strains did not differ
82

significantly. We next compared recovery in terms of bacterial density within vegetations.
No significant differences were observed when the recovery levels were normalized by
vegetation mass. We also compared bacterial levels in the blood just prior to sacrifice.
There was also no significant difference in bacteremia levels among the three strains.

Assessment of pathology among strains
We next examined pathology resulting from infection by comparing mortality,
weight loss, and vegetation mass among the groups of rabbits. As shown in Fig. 13A, two
rabbits each inoculated with comCDE and comX mutants died on day four, while all eight
rabbits infected with JFP36 survived until day 5. Kaplan-Meier survival analysis indicated
there was no significant difference in mortality among the groups. Since weight loss has
previously been shown to be a reliable indicator of IE severity in a rabbit model (34),
infected rabbits were weighed daily throughout the study. As shown in Fig. 13B, total
weight loss after five days of infection did not differ significantly among rabbits infected
with each strain. Likewise, no significant differences among groups were observed on days
1 – 4 post-infection (data not shown). Figure 13C shows the masses of vegetations
recovered at the end of the five-day infection. Our results indicated no significant
differences in vegetation mass for rabbits infected with each of the three strains. Further,
no consistent morphological differences were observed upon gross examination of the
vegetations (data not shown). Taken together, our results suggest that the S. sanguinis com
regulon is not required for IE virulence or pathology under a variety of assay conditions,
and that deletion of the comCDE genes may, in fact, modestly increase virulence.
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Figure 12. Examination of chain length variation among JFP36 and com mutants
Strains indicated were harvested in PBS prior to endocarditis study. Top indicates
strains prior to sonication and bottom following 3 min sonication at 50% power. Strains
were adjusted to OD660 corresponding to 108 CFU/ml. Images were taken at 400X
magnification on a phase contrast microscope.
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Figure 12.

Table 5. Recovery of S. sanguinis strains from experimentally infected rabbits
Vegetationa

Blooda

Strain

Total CFU

CFU/g

CFU/ml

JFP36

1.7 x 108

8.5 x 108

1.2 x 103

(1.6 x 106 - 1.8 x 1010) (1.7 x 107 - 4.6 x 109)
comCDE 9.8 x 108

comX

a

4.1 x 109

(3.0 x 101 - 5.0 x 104)
2.9 x 103

(1.7 x 108 - 5.7 x 109)

(1.5 x 109 - 1.1 x 1010)b (1.8 x 102 - 4.4 x 104)c

4.4 x 108

2.6 x 109

1.0 x 103

(8.6 x 107 - 2.2 x 109)

(9.4 x 108 - 7.2 x 109)b

(1.8 x 102 - 6.1 x 103)c

Geometric Mean (upper and lower 95% confidence interval). N = 8 rabbits, except as

indicated.
b

N =7

c

N =6
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Figure 13. Assessment of IE pathology in rabbits inoculated with JFP36 or com
mutants.
Rabbits were inoculated with 108 CFU of JFP36, JFP49 (comCDE), or JFP45 (comX). Data
were combined from two separate experiments, each of which included all three strains.
(A) Survival curve.
(B) Total weight loss 5 days post-infection. Horizontal dashed line represents no weight
loss.
(C) Mass of aortic valve vegetations 5 days post-infection.
For B and C, each symbol represents the value from a single rabbit, and horizontal lines
indicated geometric means. No significant differences among strains were observed in any
of the analyses.
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Figure 13.
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DISCUSSION
As seen in Chapter 3, deletion of either comCDE, which activates the early com
genes, or comX, which is required for the late response, produced the identical phenotype
of eliminating competence in S. sanguinis. We did not want to assume that the same would
be true with regard to com regulon functions other than genetic competence. A number of
early com regulon genes with functions involving cell lysis, virulence and biofilm
formation have been identified in other streptococcal species, and some have been shown
to be expressed in a comX mutant (127, 131, 161). If one of these genes encodes a
virulence factor, comCDE mutation would be expected to reduce virulence while a comX
mutation would not. Conversely, instances of activation of ComX-dependent genes in the
absence of comCDE have also been reported (44, 103, 120, 121). Thus, a ComXdependent virulence gene might be expressed in a comCDE mutant, but not in a comX
mutant. Finally, different comD mutations have been shown to either increase or decrease
S. pneumoniae colonization depending on their effect on comE expression (80). We
therefore chose to examine virulence both in a mutant deleted for the entire comCDE
operon and in a mutant deleted for comX.
Using a variety of assays and measures, we determined that neither comCDE nor
comX-dependent genes were required for IE virulence in S. sanguinis using our rabbit
model of IE. Our study appears to be the first to examine the effect of comX mutation on
streptococcal virulence for any disease, although ComX-dependent genes encoding
competence protein CoiA, a choline-binding protein CbpD, and the LytA autolysin were
identified as contributing to virulence for pneumonia in a mutant screen of S. pneumoniae
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(55). Comparison of the virulence of a comX mutant to strains possessing mutations in
each of these genes and in comCDE could clarify the role of the comX gene for virulence
in S. pneumoniae.
As far as we are aware, the effect of comCDE deletion on virulence has been
examined previously in only one other streptococcal species, S. mutans, where it was
shown that a comCDE mutant had reduced cariogenicity in a rat model (94). The
mechanism was not determined, but one possibility is suggested by reports that com
regulon induction causes cell lysis by mechanisms that include activation of bacteriocins
and autolysins (81, 127, 159) and, further, that lysis contributes to increased biofilm
formation (95, 126, 129, 169). The ability to form biofilms has been shown to be critical
for cariogenicity of S. mutans, likely by contributing to adherence to the tooth surface and
by providing a carbohydrate source for nutrition and acid production (53, 111). A
reduction in biofilm formation in a comCDE mutant might thus explain the strain’s
reduced cariogenicity. This study also determined that CSP enhances biofilm formation in
S. sanguinis in a comCDE-dependent manner. Unlike the case in S. mutans, however, S.
sanguinis mutants completely deficient for in vitro biofilm formation (due to mutations in
non-com regulon genes) are unaffected in IE virulence, using our rabbit IE model (47).
Therefore, biofilm reduction resulting from comCDE mutation would not be expected to
reduce IE virulence in S. sanguinis.
Given the distinct nature of caries formation, S. pneumoniae studies of com mutants
may provide a more relevant comparison. In S. pneumoniae, studies employing comD
mutants have reported attenuated virulence in murine models of respiratory tract infection
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(8, 55, 86), systemic infection (8), and bacteremia (86). As with S. mutans, the mechanisms
by which comD contributes to virulence in S. pneumoniae are not known. It has been
shown that com regulon induction in S. pneumoniae induces cell lysis by mechanisms
related to those in S. mutans (49, 60). It has also been shown that comCDE-dependent cell
lysis in S. pneumoniae results in release of the cytoplasmic virulence factor pneumolysin
(49). This is likely mediated at least in part by the major autolysin, LytA, encoded by a
com regulon gene (12, 131). This could explain not only the reduced virulence of these
mutants in assays examining pathology or death, but also the increased fitness for
asymptomatic upper respiratory tract carriage of a comE mutant (80), since in this
environment, it may be beneficial to avoid damaging host tissue. It is not clear whether
com-dependent lysis occurs in S. sanguinis or not, but it was interesting to note the 1.4-fold
advantage of the S. sanguinis comCDE mutant in the competition assay. This was
accompanied by a slight increase in growth of this mutant in BHI broth culture compared
to SK36 or JFP36 (data not shown). It is possible that this was the result of comCDEdependent cell lysis in the wild-type strains. This could suggest that IE virulence in S.
sanguinis is more akin to S. pneumoniae colonization than to pneumonia or other invasive
diseases. This would be consistent with our findings that S. sanguinis endocarditis appears
to mainly involve continued growth of the bacteria resulting in progressive enlargement of
the infected vegetation, as opposed to the myocardial abscess formation that often occurs
with other IE pathogens such as Staphylococcus aureus (9). This would also be consistent
with a recent finding that an endocarditis isolate of S. sanguinis was defective for
competence (170). In summary, then, com regulon activities apparently required for
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virulence in S. mutans and S. pneumoniae may also occur in S. sanguinis but appear to play
no role in IE virulence. It would be of interest to examine a comCDE mutant of
Streptococcus mitis for IE virulence since this species is similar to S. sanguinis with regard
to frequent isolation from IE cases, but is phylogenetically closer to S. pneumoniae and
possesses a pneumolysin ortholog (31).
Our study was also useful for defining the limits of the rabbit IE model. We found
that inoculum levels of 105 to 106 CFU were insufficient to ensure infection. Although this
would not preclude their use in ID50 studies, larger inocula are clearly required to obtain
meaningful results from competition assays. We also explored the use of infection periods
longer than the 2 and 20-hr periods we have employed previously in this model (25, 47,
122, 157). Four deaths occurred prior to the end of study, all on day four. This is in
contrast to the 20-hr infections performed here, in which no animals died prematurely, as
well as our previous experiments with this model, in which premature deaths have been
exceedingly rare (unpublished data). Upon necropsy, we observed that vegetations in all
animals were far larger than we typically observe, averaging 182 mg in this study
compared to 59 mg for a previous study (157) employing a 20-hr infection (P = 0.0034;
unpaired t test). This may have caused congestive heart failure by occluding blood flow, or
have resulted in embolic stroke. We therefore suggest that any future studies with this
model be limited to three days’ duration, at least when applied to S. sanguinis.
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CHAPTER 5: ANALYSIS OF COM GENES IN S. SANGUINIS
BIOFILM DEVELOPMENT AND ENHANCEMENT

RATIONALE:
Previous studies in S. mutans and S. pneumoniae have indicated that the com
regulon is involved in biofilm formation (95, 119). The link between competence genes
and biofilm development in other streptococci, the beneficial role of S. sanguinis in the
oral environment, and evidence of DNA exchange within this niche prompted our
investigation of S. sanguinis com regulon genes in relation to biofilm formation. Here we
examine functions of the S. sanguinis com regulon beyond DNA uptake, to investigate its
importance in biofilms.

RESULTS:
Quantitative examination of the contribution of the com regulon to biofilm formation
To determine whether the S. sanguinis com regulon plays a role in biofilm
development, we first examined SK36, the isogenic comCDE and comX mutants , and an
in-frame comC deletion strain created previously (136) for biofilm formation using a
standard CV assay (118). The optical density of the solubilized stain, commonly used as a
measure of biofilm abundance (47, 118), is indicated in Fig. 14A. Similar staining was
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observed in SK36 and the comC and comCDE mutants. However, the comX mutant
biofilm retained 2.3-fold more stain than SK36 (P< 0.001).
Previous studies in other streptococcal species have demonstrated involvement of
the com regulon in biofilm formation by treatment of cells with exogenous CSP (119, 129,
169). We therefore examined the effect of added CSP on biofilm development in S.
sanguinis. Biofilms were allowed to form in the presence of 220 ng/ml CSP, a level
previously shown to be optimal for competence induction in the comC mutant, JFP41
(136). As indicated in Fig. 14B, addition of CSP significantly enhanced biofilm staining in
SK36 and the comC mutant (P< 0.001), both of which are capable of com regulon
activation by CSP. No enhancement was observed in the comCDE mutant, suggesting that
CSP exerted its effect through the com regulon.
We observed no enhancement in biofilm formation in the comX mutant upon
addition of CSP. One possible explanation for this finding was that autologous CSP
production is sufficient to produce the biofilm-enhancing effect in this strain.
Alternatively, the mutation could exert its effect independently of CSP. To distinguish
between these possibilities, we constructed a comXcomC mutant, JFP60, and assessed it for
biofilm formation using the same assay. Fig. 14B indicates that the level of biofilm
formation in a comXcomC mutant was not significantly different from SK36 in the absence
of added CSP. However, addition of CSP to a comXcomC mutant increased biofilm levels
significantly (P< 0.001), to that of the comX mutant. Taken together, our results
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Figure 14. Examination of biofilm formation in SK36 and selected com mutants by
crystal violet staining
The strains indicated were assessed for biofilm formation in the
(A) Absence and
(B) Presence of exogenous CSP, with CV staining reported as OD600. Means and SD
values derived from three independent assays are shown. White bars, no CSP; black bars,
plus CSP. A. *, significantly different from SK36 (P<0.001).
B. *, significantly different from the same strain to which no CSP was added (P<0.001).
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Figure 14.

A.

B.
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demonstrate that CSP enhances biofilm formation, and that this enhancement requires
ComDE but not ComX.
Examination of the contribution of the com regulon to biofilm structure
We next examined the morphology of the biofilms produced by these strains.
CLSM was used to visualize 20-h biofilms reacted with a live-dead stain on polystyrene
plates. As seen in the representative CLSM micrographs in Fig. 15, both SK36 and the
comC mutant produced relatively uniform biofilms with distinct chains apparent. The
comC mutant biofilms were, however, somewhat less dense. Addition of CSP to SK36 and
comC appeared to slightly increase biofilm dispersion and height. In contrast, the comX
mutant biofilm exhibited striking differences, producing denser, punctate biofilms with
notable red and yellow fluorescence, and with clumps rather than clearly discernable
chains. The comCDE and comXcomC mutants were also examined by CLSM, and also
exhibited biofilms similar to those produced by the comC mutant. CSP addition had no
effect on biofilm appearance in the comCDE or comX mutants, in agreement with
expectation established from biofilm assay. When CSP was added to the comXcomC
mutant, its appearance was altered dramatically and became similar to that of the comX
mutant.
Biofilm surface topology was also examined by scanning electron microscopy
(SEM), as shown in Fig. 16. SK36, comCDE, comC, and comXcomC mutant biofilms
were again similar in appearance, with distinct chains prominent within a tight meshwork,
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interspersed with occasional and inconsistent cracks or gaps. In contrast, comX mutant
biofilms possessed altered structures with large gaps, often producing mushroom-like
structures. CSP addition had little observable effect on biofilm appearance in SK36, and
the comC, comCDE or comX mutants. However, as in CLSM, addition of CSP, altered the
comXcomC mutant’s appear to mirror that of the comX mutant. The combined results
suggest that induction of the com regulon by CSP significantly increases biofilm biomass,
and that induction of early com genes in a comX mutant produces a biofilm with a
dramatically altered architecture.
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Figure 15. Microscopic examination of biofilms using Confocal Laser Scanning
Microscopy
Strains were examined in the (A) absence or (B) presence of exogenous CSP, as indicated.
Biofilms stained with live/dead stain visualized by CLSM at 400 x. In each image, top
panels represent the xy plane; bottom panels represent the xz plane. The white line
indicates the z-projection for the corresponding image and was selected at the midpoint of
the biofilm height.
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Figure 16. Scanning Electron Microscopy examination of biofilms
SEM of biofilms formed on glass coverslip in the (A) absence or (B) presence of
exogenous CSP as indicated, displayed at 2,000x.
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Figure 16.

Identification of a gene responsible for com-dependent biofilm enhancement
We next sought to identify the gene(s) responsible for the CSP-dependent
enhancement of biofilm formation. Given our finding that this increase required functional
comDE genes and occurred in the absence of a functional comX gene, we hypothesized that
upregulation of a gene belonging to the early com response was responsible for CSPdependent biofilm enhancement. This laboratory’s recent transcriptomic analysis of a
comC mutant using microarray (136) and qRT-PCR suggested that the S. sanguinis early
response is comprised of only six genes: comCDE, comX, SSA_1889, and SSA_0195.
Having tested the role of the first four genes in biofilm formation, we turned our attention
to the others. SSA_1889 is annotated as a conserved uncharacterized protein. Apart from
alleles in other S. sanguinis genome-sequenced strains, its closest match in GenBank is a
hypothetical protein from S. anginosus (ZP_08014095.1). SSA_0195 is annotated as a
hypothetical protein whose closest matches are also alleles from other S. sanguinis strains,
followed by a hypothetical protein from Streptococcus cristatus (ZP_08059937.1).
SSA_0195 also possesses weak similarity to the S. pneumoniae immunity protein ComM
(60).
Because we have previously determined that these genes are not required for DNA
uptake (136), mutants of SSA_1889 (JFP65) and SSA_0195 (Ssx_0195) (23)were next
examined for biofilm formation. The results of a CV biofilm assay are shown in Fig. 17.
Similar levels of biofilm formation were observed in SK36 and the SSA_1889 and
SSA_0195 mutants in the absence of added CSP. As in SK36, biofilm formation was
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significantly enhanced by CSP in the SSA_1889 mutant (P<0.001). In contrast, CSP failed
to enhance biofilm staining in the SSA_0195 mutant. To confirm no morphological
differences in SSA_0195 biofilms, we examined biofilms produced in the absence and
presence of CSP by SEM. As seen in Fig. 17 B, SSA_0195 mutant biofilms did not vary
from those produced by SK36 (cf. Fig. 16) either in the presence or absence of CSP.
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Figure 17. Examination of biofilm formation in SK36 and selected mutants by CV
staining
A. The strains indicated were assayed for biofilm formation ± exogenous CSP as in Fig.
14. Mean and SD values derived from three independent assays are shown. White bars,
no CSP; black bars, plus CSP; *, significantly different from the same strain to which no
CSP was added (P<0.001).
B. SEM of SSA_0195 mutant biofilms formed on glass coverslip in the absence or
presence of exogenous CSP as indicated, displayed at 2,000x.
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Examination of SSA_0195 in biofilm enhancement
Our findings suggested that SSA_0195 was required for CSP-dependent biofilm
enhancement. To determine whether this gene was also sufficient for this phenotype, we
sought to examine the effect of overexpressing SSA_0195. We employed a plasmid that
has been used for IPTG-inducible expression in Bacillus subtilis, pDR110 (a kind gift from
David Rudner, Harvard Medical School). To confirm that this expression system would
function in S. sanguinis, we cloned the gfpmut3* gene from pCM18 (54) encoding green
fluorescent protein (GFP) into the pDR110 expression site. We then transferred the
gfpmut3* gene and flanking pDR110 regulatory sequences into the E. coli-streptococcal
shuttle vector, pVA838 (100), transformed SK36 with this plasmid, and confirmed IPTGinducible expression of GFP by Western Blot analysis (data not shown). We then similarly
cloned SSA_0195 into pDR110 to produce plasmid pJFP93 (Fig. 18A) and then into
pVA838 to produce plasmid pJFP94 (Fig. 18B), as described in Materials and Methods.
We next transformed the SSA_0195 mutant with pJFP94, and the resulting strain was
assessed for biofilm formation with increasing concentrations of IPTG. As shown in Fig.
19A, an IPTG dose-dependent increase of biofilm staining was observed, with a maximum
response occurring at 62.5 μM IPTG. This suggested that increased expression of the
SSA_0195 gene in response to CSP might be sufficient for the CSP-dependent biofilm
enhancement observed in our earlier experiments. However, since the SSA_0195 mutant
possesses an intact comC gene capable of producing CSP, and the ComDE receptor and
activator, we could not be certain that induction of other early com genes was not also
required for increased biofilm formation. We therefore introduced pJFP94 into the comC
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mutant, JFP41. As shown in Fig. 19A, JFP41 (pJFP94) also demonstrated increased levels
of biofilm formation in response to IPTG. This suggested that upregulation of early com
regulon genes by intrinsic CSP production is not required in addition to SSA_0195
upregulation for augmentation of biofilm formation. Indeed, CV staining was significantly
(P<0.05) greater in the comC (pJFP94) mutant relative to Ssx_0195 (pJFP94) at IPTG
concentrations up to 32 µM, after which similar levels of biofilm formation were observed
in both strains.
As shown in Fig. 19B, biofilms were also examined by CLSM in the presence or
absence of IPTG at 125 µM—a concentration beyond which increased biofilm staining did
not occur in the CV assay. Mutation of SSA_0195 resulted in reduced biofilm density
compared to SK36 (cf. Fig. 15A). Overexpression of SSA_0195 in Ssx_0195 (pJFP94)
resulted in increased fluorescence relative to that of the Ssx_0195 mutant. JFP41 (pJFP94)
biofilms formed in the presence of IPTG also exhibited an increase in biofilm fluorescence
relative to JFP41 (cf. Fig. 15A), and the addition of CSP had little effect. Taken together,
our results indicate that upregulation of SSA_0195 is sufficient to cause CSP-dependent
biofilm enhancement.
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Figure 18. Plasmid Maps of pJFP93 and pJFP94
A) SSA_0195 and native RBS were placed under the control of IPTG inducible promoter
Pspank in Bacillus subtilis plasmid pDR110 via unique 5’ SalI and 3’ SphI sites to create
pJFP93.
B) An EcoRI/BamHI fragment containing the Pspank promoter, SSA_0195, and lacI from
pJFP93 was ligated into the EcoRI/BamHI sites of the E. coli-streptococcal shuttle vector
pVA838 to create pJFP94.
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Figure 19. Analysis of the effect of SSA_0195 expression on biofilm formation
(A) The strains indicated were assayed for biofilm formation as in Fig. 14, except that
biofilm formation occurred in the presence of IPTG at the concentrations shown. The assay
was performed three times in quadruplicate, and a representative assay is shown. *, value
significantly different from Ssx_0195 (pJFP94) at the same IPTG concentration (P<0.05).
(B) CLSM of SK36 derivative strains ± 125 μM IPTG and CSP at 400x.
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Figure 19.

In S. pneumoniae, ComX functions not only to upregulate late genes, but also to
shut down early com gene transcription, through activity of one of more of its late gene
products (88). If this is also true in S. sanguinis, a comX mutant would be expected to
exhibit upregulation and perhaps continuous expression of early genes. In an S. sanguinis
comX mutant, we observed an altered, dense, and punctate biofilm. This was also seen in
biofilms of a comXcomC mutant (Figs. 15 & 16) with added CSP. The simplest
explanation for this phenotype was that overexpression of the early gene SSA_0195 in the
absence of ComX was responsible. We did not observe an altered phenotype when
SSA_0195 was overexpressed in strain JFP96. However, because this strain contains
comX, we couldn’t be sure that comX was not being expressed at low levels, thereby
altering the biofilm phenotype. We therefore tested this possibility by overexpressing
SSA_0195 in a comXcomC mutant (JFP114). As seen in Fig 20A, overexpression of
SSA_0195 by IPTG addition to JFP114 increased biofilm straining relative to plasmid
control, but did not produce a biofilm with a punctate phenotype unless CSP was added.
Taken together these findings suggest that overexpression of an early gene other than
SSA_0195, in the absence of comX, was necessary for the comX mutant phenotype.
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Figure 20. Analysis of the effect of SSA_0195 expression on biofilm formation in a
comXcomC mutant
CLSM of SK36 derivative strains ± 125 μM IPTG and ± CSP at 400x.
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Figure 20.

Examination of the effects of CSP on cell growth or survival
We next sought to examine the mechanism by which SSA_0195 enhances biofilm
formation. CSP-dependent cell lysis accompanied by DNA release has been observed
previously in other streptococcal species (126, 141), and has been linked to enhancement
of biofilm formation (95, 96, 129). To determine whether this was also occurring in S.
sanguinis, we first examined the effect of exogenous CSP on growth kinetics. CSP
treatment of the comC mutant caused a marked delay in growth as measured by optical
density (Fig. 21A), which is consistent with CSP-mediated cell killing or growth
inhibition. However, CSP had little effect on the growth of SK36. One explanation we
considered for this based on data described below is that addition of CSP at high
concentrations to CSP-naïve cells might produce a greater effect than when CSP was
added to cells producing autogenous CSP. This could occur if exposure to low levels of
CSP provided partial tolerance to higher levels. The comCDE mutant grew as well as
SK36 in the presence or absence of CSP, suggesting the CSP growth attenuation observed
in the comC mutant is mediated through the com regulon. We predicted that if the CSP
effect on growth, like its effect on biofilm formation, was dependent on SSA_0195
expression, then the SSA_0195 mutant would grow equally well in the presence and
absence of exogenous CSP. There was indeed only a minor effect of CSP on growth of the
SSA_0195 mutant; however, growth was significantly impaired in this strain in the
absence of CSP relative to SK36 at all time points from early exponential growth until the
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beginning of stationary phase. Thus, mutation of SSA_0195 appeared to modestly reduce
viability or growth regardless of added CSP.
To clarify the role of SSA_0195 in CSP-mediated growth attenuation, we next
examined strains overexpressing SSA_0195, along with their plasmid controls, using the
same assay. We hypothesized that if SSA_0195 were responsible for the growth effect, an
overexpressing strain would exhibit a reduced growth rate relative to a plasmid control. As
seen in Fig 21B, overexpression of SSA_0195 in Ssx_0195 (pJFP94) did not affect its rate
of growth relative to its plasmid control strain, Ssx_0195 (pVA838). Additionally, the
growth rates of both strains were lowered by CSP. This suggested that the CSP effect on
growth was independent of SSA_0195 expression. We also examined JFP41 (pJFP94). As
seen in Fig. 21C, overexpression of SSA_0195 in JFP41 (pJFP94) significantly enhanced
the growth rate relative to the plasmid control, JFP41 (pVA838), which would not be
expected if CSP-dependent growth inhibition were mediated by SSA_0195
overexpression.
As another test of the effect of CSP on growth or viability, we performed standard
transformation assays in which cells were exposed to DNA in the presence and absence of
exogenous CSP for 90 minutes and then plated for viable counts in the absence of
antibiotics. As seen in Fig. 21D, addition of CSP significantly reduced the number of CFU
recovered for the comC mutant compared to no CSP addition (P<0.02). SK36 and
comCDE mutant CFU were not affected by CSP. Viable counts of the SSA_0195 mutant
appeared slightly reduced, but this difference was not significant (P=0.15). As with the
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Figure 21. Examination of the effect of CSP on growth and viable counts of S.
sanguinis strains
(A – C) Optical densities of strains grown in THHS in the presence (+) or absence (-) of
added CSP.
A) SK36 and early com mutant strains
(B and C) Strains containing SSA_0195 expression plasmid pJFP94 or the control plasmid
pVA838, and grown in the presence of 125 μM IPTG. For A – C, error bars were removed
for clarity. Assays were performed in triplicate and the mean values of a representative
assay are shown. Closed symbols and solid lines, no CSP; open symbols and dashed lines,
plus CSP.
(D) Percent recovery of selected strains following incubation with CSP compared to no
CSP treatment. * Significantly different from the same strain to which no CSP was added
(P<0.05).
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growth studies, these results were consistent with a CSP-dependent, com regulondependent reduction in viability or growth in CSP-naïve cells.

Examination of DNA in S. sanguinis biofilms
Although we could not demonstrate cell death as a result of increased SSA_0195
expression, we nevertheless looked for evidence that CSP-dependent biofilm enhancement
resulted from incorporation of extracellular DNA into the biofilm. DNase I was added to
the biofilm medium ± CSP in varying concentrations at the onset of biofilm formation in
SK36, a comC mutant, and a comX mutant. In SK36, CV staining was significantly
reduced in both the presence and absence of CSP by addition of DNase I at concentrations
≥100 units/ml (Fig. 22A). A similar result was observed for the comC mutant (Fig. 22B).
These findings suggest that extracellular DNA is a component of S. sanguinis biofilms, and
that activation of the com regulon is not required for its incorporation. Interestingly, comX
mutant biofilms were more sensitive to DNase I than biofilms from the other strains,
demonstrating significantly reduced staining with only 50 units/ml DNase I (Fig. 22C), in
the presence or absence of exogenous CSP.
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Figure 22. Effect of DNase I on biofilm formation in the absence and presence of
exogenous CSP
Biofilm formation was examined by CV staining as in Fig. 14, except that biofilm
formation occurred in the presence of DNase I at the concentrations indicated. The assay
was performed three times in quadruplicate and the mean values and SD of a representative
assay are shown. (A) SK36 (B) JFP41 (C) JFP45. *, significantly different from cells
grown in the same condition (either with or without CSP) in the absence of DNase I
(P<0.05); the symbol applies to both samples in all cases.
D) Polystyrene plate showing biofilm strains treated with DNaseI, stained with CV
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DISCUSSION
Our examination of the contribution of the com regulon to biofilm formation was
motivated by a number of factors. S. sanguinis principally colonizes teeth (1), and its
habitat is therefore primarily the dental plaque biofilm. DNA sequencing reveals that the S.
sanguinis genome has been shaped to a large degree by transformation (168), suggesting
its com regulon is active in biofilms. This would also be consistent with findings from S.
pneumoniae (119) where transcriptomic analyses revealed increased levels of com regulon
genes in biofilms relative to those in planktonic growth, and in S. mutans (93), where
biofilm-grown cells demonstrated increased levels of transformation compared to
planktonic cells. Moreover, these studies also demonstrated involvement of the com
regulon in biofilm formation.
We detected no differences in biofilm mass or morphology in comC or comCDE
mutants in the absence of added CSP. These findings differ from those seen in S. gordonii,
where a comD mutant failed to form a biofilm (96), and in one study of S. mutans, where
comD or comE mutants were deficient in biofilm formation (95). Our findings of biofilm
enhancement by CSP are, however, reminiscent of studies with S. pneumoniae, where CSP
dramatically enhanced biofilm formation in wild-type strains (119). Also, although
autogenous CSP production is sufficient to enhance biofilm formation in S. mutans,
addition of exogenous CSP increases biofilm formation further (129, 169). It is possible
that apparent differences in CSP requirements are largely the result of particular assay
conditions. In a recent study of S. sanguinis SK36, exogenous CSP had no effect on
biofilm formation (170). However, the culture conditions used in that study (aerobic BHI
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incubation) have been shown previously (47) to produce less biofilm than the conditions
employed here. It’s possible that further testing would reveal assay conditions in which
biofilm formation is both abundant and responsive to autogenous CSP. Considering that S.
sanguinis exists in an environment characterized by frequent changes in pH, oxygen
tension, nutrient availability, cell density, and co-resident species, there are numerous
biologically relevant conditions that could be tested.
Previous studies of CSP-dependent biofilm formation in S. mutans (129, 169) and
S. pneumoniae (119) and of CSP-dependent allolysis (49) and cell clumping (60) in S.
pneumoniae suggest these processes are related. Published findings are largely consistent
with a model in which CSP upregulates expression of bacteriocins and/or cellular
autolysins, which results in increased cell lysis and increased release of extracellular DNA,
which then increases biofilm formation (or clumping) in a manner that requires binding of
the DNA to the cell surface. The CSP-dependent reduction in cell culture densities and
viable counts observed in our study was consistent with this model. Other results, however,
were not. First, our data suggested CSP-dependent effects on cell numbers were greatest
when CSP was added to strains capable of CSP sensing but not production, whereas the
CSP effect on biofilm augmentation was unaffected by the strain’s capacity for autogenous
CSP production. Thus, the effects of CSP on cell numbers and biofilm augmentation were
genetically separable. Second, the effect of CSP on biofilm enhancement appears to result
directly from induction of SSA_0195 expression; thus SSA_0195 overproduction from an
IPTG-induced promoter would be expected to have the same effect on cell numbers as
addition of CSP. This outcome was not observed. Third, in strains capable of CSP sensing,
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this model predicts increased cell lysis and extracellular DNA in the biofilms of cells
treated with CSP compared to untreated cells. With the staining method employed in our
CLSM analysis, intact cells are expected to appear green while cells with impaired
membranes should appear red or yellow, as should extracellular DNA (50). Yet, there was
very little increased red or yellow staining in biofilms formed from cells treated with CSP
as compared to untreated (Fig. 15 for SK36 and comC mutant). Likewise, there was little
effect on red or yellow staining in biofilms of cells induced to overexpress SSA_0195 as
compared to uninduced. Fourth, DNase I treatment produced similar effects on biofilms,
regardless of whether CSP was present, suggesting that DNA plays an important structural
role in biofilms of cells in the absence of CSP. Finally, in the simplest form of this model,
the SSA_0195 gene would encode a bacteriocin or an autolysin. Yet, SSA_0195 has no
detectable sequence similarity to known members of either class, and is instead similar to
the ComM immunity protein from S. pneumoniae that functions to protect cells from the
CSP-dependent lytic activity of the putative murine hydrolase CbpD and autolysins LytA
and LytC (38, 60).
Whether SSA_0195 functions as an immunity protein in S. sanguinis or how such
an activity would lead to biofilm enhancement is not clear. Mutation of SSA_0195 resulted
in a significant decrease in culture density at multiple time points in our growth study,
suggesting the protein provides a modest growth or survival benefit to the cell. While this
is consistent with an immunity function, many alternate explanations are possible, and the
effect of SSA_0195 appears unrelated to CSP exposure. Bioinformatic analysis may
provide important clues. ComM and SSA_0195 share only 23% amino acid identity and a
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BlastP alignment e value > 10-5. (This explains why the ComM protein, SP_1945, was not
categorized as an SSA_0195 ortholog in a previous study performed by our lab (136)).
However, both proteins are reciprocal best matches by BlastP analysis and are both
encoded by genes belonging to the early com response (60, 77, 131, 136). Interestingly,
topological analysis using either TMHMM (82) or TMMOD (71) suggests that both
proteins possess five transmembrane domains in virtually identical locations, but that
ComM possesses a sixth transmembrane domain that results in the C terminus being
internal to the cell, whereas the analogous region in SSA_0195 is predicted to be external
(data not shown). Since the mechanism by which ComM confers immunity to its own
lysins has not been determined and functional domains have not been identified (60), the
significance of this topological difference is unknown.
Finally, our results suggest that ComX plays a role in biofilm formation distinct
from that of SSA_0195. comX mutant biofilms possess altered architecture, increased
staining with CV, increased staining with propidium iodide indicative of increased cell
death or release of DNA, and increased sensitivity to DNase I. This suggests that CSPstimulated biofilm production requires one or more ComX-dependent genes for normal
architecture. This laboratory has previously identified 118 late genes in S. sanguinis (136),
any of which may be responsible. In S. mutans, the ComX-dependent gene comGB
required for DNA uptake and transformation was also shown to be involved in biofilm
formation (129). Disruption of comGB reduced both CSP-dependent biofilm enhancement
and binding of extracellular DNA to cells. Together with the finding that DNase I
treatment reduced biofilm formation in wild-type cells, but not in the comGB mutant, these
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results suggested that ComGB enhances biofilm formation by binding to extracellular
DNA. It is possible that in S. sanguinis the ComGB ortholog (SSA_0185) or other ComXdependent proteins required for DNA uptake also affect biofilm architecture. However, the
effect of ComX on biofilm formation in the two species is distinct. In S. mutans, a comX
mutant produces a biofilm with decreased staining and appearance indistinguishable from
that of a comD, or comE mutant (95). This also suggests that the CSP-dependent biofilm
enhancement observed in S. mutans can be explained by its effect on comX expression.
This is clearly not the case in S. sanguinis.
Another notable finding was that it was not necessary to add CSP to observe a
change in biofilm architecture in a comX mutant. Together with the finding that exogenous
CSP is required to reproduce the comX phenotype in the comXcomC mutant, this suggests
that the comX mutant may produce increased CSP compared to SK36. We attempted to
compare CSP levels in culture supernatants of these two strains grown for various
durations under biofilm conditions by assaying for their capacity to induce competence
when added to a comC mutant. Unfortunately, these experiments were unsuccessful. In
wild-type S. pneumoniae, early genes are transcribed maximally 7.5 to 10 minutes after
CSP addition and then return to baseline levels for 40 to 60 min before undergoing another
cycle of activation (88, 131). The decline in transcription is largely alleviated in a comX
mutant, suggesting it is mediated by a ComX-dependent gene (131). If this also occurs in
biofilm-grown S. sanguinis, then the comX mutant may experience higher or more
sustained SSA_0195 expression in the absence of exogenous CSP leading to an increase in
biofilm.
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Also within the comX mutant, it is not merely the absence of comX, but the absence
of comX coupled with early gene expression, that results in an altered biofilm phenotype.
We propose that, as in S. pneumoniae, under WT conditions, a comX dependent gene
product serves to dampen the expression of early genes. We further propose that in this
regulator’s absence, the expression of the early genes remains high, leading to increased
biofilm levels, cell death and an aberrant structure. Although overexpression of SSA_0195
in a comX+ strain resulted in an increase in the total amount of biofilm present, it did not
result in a biofilm with aberrant structure in a comXcomC background. . However, when
CSP was added to the overexpressing strain in a comXcomC background, thereby turning
on the expression of other early genes, the altered biofilm reappeared. This suggests that
upregulation of a different early gene is responsible for the altered biofilm phenotype of a
comX mutant. This possibility, as well as the mechanism by which SSA_0195 enhances
biofilm formation, are currently under investigation.
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CHAPTER 6: SUMMARY AND PERSPECTIVES

This study sought to further characterize the S. sanguinis com regulon and
determine any involvement of this system in endocarditis virulence and biofilm formation.
As described in chapter 1, S. sanguinis is able to colonize two very different niches—the
oral cavity and cardiac valves. S. sanguinis is naturally competent, and its ability to acquire
new DNA may add to competitiveness in both environments. There is already evidence
this process appears to have played an important role in shaping the genome of S.
sanguinis (168).
In chapter 3, we first demonstrated that several early and late com regulatory genes
required for DNA uptake in the model organism S. pneumoniae were also required in S.
sanguinis. Additionally, we sought to further characterize a unique aspect of the S.
sanguinis com regulon by determining the sequence of processed and secreted CSP and
identify the transport system involved in its processing and export. The cleavage site for
ComC was identified and the sequence of the leader peptide did not appear to possess a
sequence similar to any characterized peptide processing motif. This suggests a novel
signal sequence in peptide transport. Further it should be noted that determination of the
exact mass and sequence, through Sequest analysis, of CSP reinforced the authenticity of
studies performed in chapters 3 and 5 with synthetic CSP. This also includes a recent
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microarray study performed within this lab (136). Additionally, despite a thorough screen
of candidate transporter systems, the protein responsible for ComC processing was not
identified. Future studies are planned to examine this question. These studies will
examine ComC processing within a heterologous host, S. gordonii. Here comC will be
placed under control of the Pspank promoter on shuttle plasmid pVA838. First, we will
assure it is not being secreted by a non-dedicated transporter. Assuming this is not the
case, we will next create plasmid DNA libraries with fused ~ 3 kb fragments of S.
sanguinis DNA cloned downstream of comC. Strains transformed with these plasmids will
then be grown in the presence of IPTG and filtered supernatant will be assessed for gain of
function in JFP41, the S. sanguinis comC mutant.
Once the comCDE and comX regulatory genes were shown to function as expected,
we next assessed potential involvement of these genes in endocarditis virulence. The data
we have presented in chapter 4 is the first to our knowledge to examine possible roles of
the com regulon in IE virulence for any bacterium. Using a variety of assays and measures
within our rabbit endocarditis model, we determined that neither ComE nor ComXdependent genes contribute to endocarditis infection, bacteremia or pathology.
Collectively, there are approximately 124 genes under the control of these two regulators.
Given the genome of S. sanguinis contains about 2274 genes; this study has substantially
contributed to screening potential genes which may contribute to IE virulence.
Chapter 5 examined the role of the com regulon within S. sanguinis biofilm
formation and indicated this system plays an important role in biofilm development. Using
both quantitative and qualitative assessment, we have determined biofilm development
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requires the coordination of early genes for enhancement and late genes for maintaining
normal structure. CSP-enhancement of biofilms within S. sanguinis was demonstrated to
be com regulon dependent, occurring through the activity of early gene SSA_0195.
Overexpression of this gene alone was sufficient to increase biofilm abundance. Further,
evidence supported a role of one or more ComX-dependent genes in biofilm structure.
Despite the finding of biofilm enhancement through activity of SSA_0195, its mode of
action with regard to biofilm enhancement and planktonic growth remain undetermined.
Growth studies indicated this gene may offer protection to the cell. Further, this study
demonstrated, as in many streptococcal biofilms, DNA appears to be an important
structural component. Its entry into the extracellular matrix may be com-independent.
Our findings have led us to propose a hypothetical model to explain S. sanguinis
biofilm formation under three conditions. Each illustration depicts predicted levels of
SSA_0195 and SSA_1889 expression, as well as biofilm amount. The first illustration
(Fig. 23A) depicts formation of a basal biofilm in untreated, wild-type cells. Here CSP is
being produced in small amounts resulting in low expression levels of early genes. As a
result, levels of SSA_0195 are basal or are increased only transiently and a minimal, comindependent biofilm is produced. A ComX-dependent protein prevents sustained, early
gene transcription. This model could explain why similar staining patterns and
morphology were observed in an SK36, comC, comCDE, and comXcomC biofilms.
In the next illustration, Fig. 23B, there is an increase in the amount of SSA_0195
expression, either through addition of CSP to the medium or through IPTG induction of the
plasmid-borne gene. In the first scenario, increased transcription of other early genes also
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occurs, including SSA_1889; however through activity of a ComX dependent protein,
some dampening occurs, resulting in expression levels that are higher than in cells
untreated with CSP, but lower than in comX mutant cells. The increased level of
SSA_0195 results in an increase in biofilm levels. When SSA_0195 is overexpressed from
the Pspank promoter, biofilm levels likewise increase.
The last illustration, Fig 23C, depicts a comX mutant biofilm. Here we propose
loss of the ComX-dependent regulator eliminates the feedback loop, leading to increased
and continuous early gene expression. In this scenario, we propose that increased
expression of SSA_0195 is increasing biofilms amounts, but that increased expression of
another gene is altering the phenotype of the biofilm and increasing cell death. One
possible candidate is SSA_1889. Alternatively, there may be another early gene that was
not detected in the microarray for any of a variety of reasons, including low expression at
time zero, as in SSA_0195.
This model could be tested by examining biofilms produced by a comX SSA_1889
double mutant to determine if this aberrant phenotype is still present. Additionally we
could examine a strain overexpressing SSA_1889 in a comXcomC background to
determine if this phenotype is present. Lastly, we could use RT-PCR to analyze com genes
expression during biofilm development in WT and mutant strains.
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Figure 23. Model of com regulon activity during biofilm formation in a variety of S.
sanguinis strains and incubation conditions
This model depicts proposed levels of gene activity by CSP or IPTG in biofilms in variety
of strains. (+) indicates minimal (++) moderate and (+++) high levels of gene expression.
Each gene is indicated by a colored arrowed, and its corresponding protein is represented
by a symbol of the same color. The hypothetical CSP exporter is indicated in purple.
Lastly, the resulting amounts and morphology of biofilm in each model is illustrated
surrounding the cell.
A. Basal biofilm
B. Increased SSA_0195 production due to IPTG induction of cloned gene or by CSP
addition
C. comX mutant
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In conclusion, this study has demonstrated the com regulon is not important in
endocarditis virulence, but is essential for biofilm enhancement and structure. Taken
together with the fact that S. sanguinis is an important component of a healthy plaque (10),
this may allow studies which investigate increasing S. sanguinis biofilm levels within the
oral cavity without increasing endocarditis virulence.
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